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Abstract (English) 
This PhD in co-direction between the Peptlab Laboratory of the University of Firenze 
(Italy) and the Laboratory of Pharmacognosy of the University of Bourgogne Franche-Comté 
(France), deals with extraction, purification and structural elucidation of saponins from plants 
as mimetic antigens involved in an immune response. 
The phytochemical study of five species from three different families, Wisteria 
frustecens, Wisteria floribunda “macrobotrys” and Wisteria floribunda “rosea” from 
Fabaceae, Weigela florida “rumba” from Caprifoliaceae, and Polygala acicularis from 
Polygalaceae, allowed us to isolate sixteen natural glycosides: six with new structures, one 
analyzed for the first time in its native form, and nine which have been already described in 
the literature. These compounds were isolated using various chromatographic methods, and 
their structures were elucidated using mainly 2D NMR and mass spectrometry. 
From the isolated glycosides, six were selected and tested as mimetics of native 
antigens involved in the immune response. Moreover, one flavonoid glycoside extracted from 
Sophora japonica, and one commercial triterpenic acid, ursolic acid, were also chosen as 
mimetics of native antigens. Immunoenzymatic assays (ELISA) were performed for each 
compound to evaluate their potential as mimetics of native antigens of multiple sclerosis and 
Rett syndrome. The IgM levels in sera of patients affected by multiple sclerosis and Rett 
syndrome were measured and compared to normal blood donors. 
Concerning multiple sclerosis, no significant results were obtained for saponins, but in 
the case of Rett syndrome, interesting and surprising results were obtained. Indeed, the first 
hypothesis was that the glycosyl part of the molecule could be relevant for antibody 
recognition. In the case of Rett syndrome ursolic acid, an aglycone without any glycosidic 
part, demonstrated a good efficiency in IgM recognition. On the other hand, one triterpenic 
glycoside showed similar results. These results were discussed to define possible 
structure/activity relationships. 
Keywords: Triterpene glycosides, NMR, ELISA tests, IgM, multiple sclerosis, Rett syndrome, 
antibodies 
 
  
Abstract (French) 
Cette these en cotutelle entre le Laboratoire Peptlab de l’Université de Florence en 
Italie et le Laboratoire de Pharmacognosie de l’Université de Bourgogne Franche-Comté en 
France, porte sur l’extraction, la purification et l’élucidation structurale de saponines d’origine 
végétale en tant que mimétiques d’antigènes impliqués dans une réponse immunitaire. 
L’étude phytochimique de cinq espèces végétales appartenant à trois familles 
différentes, Fabaceae : Wisteria frustecens, Wisteria floribunda “macrobotrys”, Wisteria 
floribunda “rosea”, Caprifoliaceae : Weigela florida “rumba” et Polygalaceae : Polygala 
acicularis, a conduit à l’isolement de seize glycosides triterpéniques naturels parmi lesquelles 
six sont de structure nouvelle, une a été isolée sous sa forme native pour la première fois, et 
neuf déjà répertoriées dans la littérature. Les composés ont été isolés grâce à l’utilisation de 
différentes méthodes chromatographiques. Leurs structures ont été élucidées en utilisant 
principalement la RMN 2D et la spectrométrie de masse.  
Parmis ces seize molécules, six ont été sélectionnées pour être testées en tant que 
mimétiques d’antigènes impliqués dans une réponse immunitaire. De plus, un flavonoïde 
glycosylé extrait de Sophora japonica et un acide triterpénique commercial, l’acide ursolique, 
ont eux aussi été choisis comme mimétiques d’antigènes. Des tests immunochimiques 
(ELISA) ont été réalisés afin d’évaluer leur potentiel en tant que mimétiques d’antigènes dans 
le sang de patients atteints de sclérose en plaque ou du syndrome de Rett. Le taux IgM dans le 
sérum des patients atteints de sclérose en plaque ou du syndrome de Rett a été mesuré et 
comparé à celui de donneurs sains. 
Concernant la sclérose en plaque, les résultats sont peu significatifs concernant le 
potentiel des saponines en tant que mimétiques d’antigènes. Mais dans le cas du syndrome de 
Rett des résultats intéressants et surprenants ont été obtenus. En effet, l’hypothèse de départ 
était l’implication de la partie glycosylée dans la reconnaissance d’autoanticorps. Pour le 
syndrome de Rett, l’acide ursolique, qui est un aglycone, démontre une grande efficacité dans 
la reconnaissance d’IgM. Par contre, un triterpène glycosylé démontre lui aussi une efficacité 
semblable. Les résultats obtenus sont donc à analyser afin d’établir des relations 
structure/activité fiables. 
Mots clés : Triterpènes glycosylés, RMN, tests ELISA, IgM, sclérose en plaque, syndrome de 
Rett, anticorps. 
Abstract (Italian) 
 
Questa tesi di dottorato in cotutela tra il laboratorio PeptLab dell’Università di Firenze 
e il laboratorio di farmacognosia dell’Université de Bourgogne Franche-Comté (Francia) 
tratta dell’estrazione, purificazione e caratterizzazione strutturale di saponine da piante, quali , 
mimetici di antigeni coinvolti nella risposta immunitaria. 
 
Lo studio fitochimico di cinque specie da tre diverse famiglie la Wisteria frustecens, la 
Wisteria floribunda “macrobotrys” e la Wisteria floribunda “rosea” dalle Fabaceae, la 
Weigela florida “rumba” da Caprifoliaceae, e la Polygala acicularis da Polygalaceae, ci ha 
permesso di isolare sedici glicosidi naturali: sei con nuove strutture, uno caratterizzato per la 
prima volta nella sua forma nativa e nove che sono già stati repertoriati in letteratura. I 
composti sono stati isolati utilizzando varie tecniche cromatografiche e le loro strutture sono 
state elucidate essenzialmente tramite 2D NMR e spettrometria di massa. 
Sei dei glicosidi isolati sono stati selezionati e utilizzati come mimetici di antigeni 
nativi coinvolti nella risposta immunitaria, così come un flavonoide glicoside estratto da 
Sophora japonica,e il triterpene derivato commerciale, l’acido ursolico. Test 
immunoenzimatici di tipo ELISA sono stati effettuati per ogni composto per valutare il loro 
potenziale quali antigeni che riconoscono anticorpi in sieri di pazienti affetti da sclerosi 
multipla e sindrome di Rett e il titolo in anticorpi è stato confrontato con quello in donatori 
sani. 
Per quanto riguarda la sclerosis multipla non sono stati ottenuti risultati significativi 
con nessuna delle saponine, ma nel caso della sindrome di Rett, sono stati ottenuti risultati 
interessanti e sorprendenti. La prima ipotesi è che la parte glicosilica sia coinvolta nel 
riconoscimento di anticorpi. Ne caso della sindrome di Rett, l’acido ursolico, un aglicone 
senza porzione glicosidica ha mostrato una buona efficienza nel riconoscimento di IgM. 
D’altra parte un triterpene glicosidico ha mostrato risultati simili. Questi risultati sono stati 
discussi per tentare di stabilire una correlazione tra struttura e attività. 
Keywords: Triterpeni glicosidici, NMR, ELISA, IgM, sclerosi multipla, sindrome di Rett, 
anticorpi 
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GENERAL INTRODUCTION 
 
Since a long time, people used plants to cure diseases. Nowadays, nature offers a large 
variety of active ingredients that have been characterized from plants. However, their 
synthesis is very often extremely complex. This is why it is important to continue performing 
phytochemical studies in order to discover new compounds with interesting pharmacological 
properties. 
The laboratory of Pharmacognosy of the University of Bourgogne Franche-Comté in 
Dijon (France) has a long experience on extraction, purification and structural elucidation of 
saponins from plants. They discovered numerous new molecules and tested them to evaluate 
their biological properties. Saponins are amphiphilic glycosides, with many in vitro properties 
in various pharmacological fields. They are rarely used in their pure form in spite of various 
pharmacological activities in vitro, due to their potential toxicity. Plants, rich in saponins, are 
used in phytotherapy, in food and cosmetic industries.  
A previous collaboration between the Laboratory of Pharmacognosy of the University 
of Bourgogne Franche-Comté (France) and the Laboratory of Peptide and Protein Chemistry 
and Biology (Peptlab) of the University of Firenze (Italy), on the use of saponins as antigens 
lead to interesting results. The Peptlab laboratory developed an N-glucosylated type I’ beta-
turn peptide structure termed CSF114 (Glc) that was demonstrated an efficient antigen to 
recognize autoantibodies in sera of patients affected by some autoimmune diseases. They 
assumed that the glucosyl moiety on an asparagine moiety was fundamental for antibody 
recognition with the idea in mind that an aberrant glucosylation could be triggered by a 
bacterial infection. This was recently published by the group. Therefore, the interest in 
glycosides gathered both laboratories. In particular, a collaboration was born around a 
common project aimed to use saponins as antigens for the recognition of different families of 
autoantibodies. Various triterpene glycosides were tested in case of patients affected by 
multiple sclerosis and interesting results were obtained which confirmed the potential role of 
glycosyl moieties. 
According to these results, the aim of my PhD was to perform the extraction, 
purification and structural elucidation of new saponins from plants and testing them as 
mimetics of native antigens involved in an immune response. Two different diseases were 
chosen for the study: Multiple Sclerosis and Rett syndrome. 
3 
 
In this manuscript, I will present the phytochemical study of five plants rich in 
triterpenic glycosides: three species of the Fabaceae family: Wisteria frustecens, Wisteria 
floribunda “macrobotrys” and Wisteria floribunda “rosea”; one species of the Caprifoliaceae 
family: Weigela florida “rumba”, and one species of the Polygalaceae family: Polygala 
acicularis. Then, after selection of some isolated and characterized molecules, Enzyme 
Linked ImmunoSorbent Assays (ELISA tests) were performed using these saponins as 
mimetics of the native antigens to recognize antibodies in collections of patient sera and 
controls.  
The present work is divided in three parts: 
In the first part, I present generalities on the immune system, autoimmunity, multiple 
sclerosis and Rett syndrome.  
In the second part, after some botanical data, a bibliographic synthesis on the family 
and the genus of the studied plants is realized. Then, the personal phytochemical study 
including techniques, methods and results are presented. 
The third part is devoted to the results of the immunoenzymatic assays after selection 
of the molecules to demonstrate the potential role of saponins as mimetics of native antigens. 
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Chapter 1: Immune-mediated diseases and diagnostics 
 
The essential functions of the immune system are to maintain the coherence of the 
cells and tissues and to ensure their integrity by rejecting foreign aggressive substances or 
infectious agents that is, the “non-self”, and the “modified self” antigens while respecting the 
normal components of the host, that is, the “unmodified self-antigens” [1]. 
1.1 Immune system 
 
Immunity is one of the most prominent examples of complex machinery merging 
together chemistry and biology to serve a very simple, yet complex purpose: protecting the 
organism against any form of external agents (Figure 1) [2]. 
 
 
Figure 1: Function of the immune system 
 
1.1.1 Innate and adaptative immunity 
 
To preserve the immune system integrity and coherence there are two strategies: 
- The innate immunity, also known as non adaptative immunity that is involved in the 
destruction of pathogen agents and prevents infections with an immediate non-specific 
response [3]. This system is present in almost all living organisms. The cells of the 
innate system are: the leukocytes (or white blood cells), the phagocytes (dendritic 
cells, monocytes, neutrophils, macrophages) and the Natural Killer cells (NK cells). 
These cells absorb pathogens to destroy them and release inflammatory mediators 
such as cytokines which stimulate other responses from the organism. Another part of 
the innate system is the complement system which is a biochemical cascade of 
reactions that can be activated to eliminate pathogens. 
- The adaptative immunity which is much more specific can create immunological 
memory after an initial response to a specific pathogen, leading to an enhanced 
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response after encountering that pathogen. The adaptative response involves T 
lymphocytes and B lymphocytes derived from the same multipotent hematopoietic 
stem cells. B cells play a role in the humoral immune response contrary to T cells, 
which are involved in cell-mediated immune responses but both are produced in the 
bone marrow [2]. 
 
1.1.2 B and T lymphocytes 
 
These cells carry on their surface highly diversified antigen-specific receptors, which 
are able to interact with a quasi-unlimited number of antigens, thanks to their structure 
diversity [3]. B cells through B cell receptors (BCRs) recognize linear or conformational 
epitopes on their own and bind intact antigens contrary to T cells, which specifically 
recognize and interact through T cell receptors (TCRs) with peptide fragments derived from 
antigens in association with major histocompatibility complex (MHC) molecules on the 
surface of antigen-presenting cells (APCs) [3]. 
 
Concerning T cells, we can distinguish the T helper cells also known as CD4+ T cells 
and the cytotoxic T cells also known as CD8+ T cells. Their interactions are different: CD4+ 
T helper cells interact with peptide-class-II-MHC compared to CD8+ cytotoxic T cells which 
interact with peptide-class-I-MHC [1]. 
 
1.1.3 Autoimmunity 
 
Autoimmunity includes pathological manifestations that can develop when the 
immune system is abnormally overactivated because of a defective regulation function and 
trigger to a strong reaction against its unmodified components. The autoimmune response 
involves classical immune responses with T cells, B cells, APCs, inflammatory cells, 
antibodies and many other mediators of immunity such as cytokines (Figure 2) [1]. 
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Figure 2: Pathological mechanisms of autoimmune diseases. IC (inflammatory cells); APC (antigen-presenting 
cell); NO (nitric oxide) [1] 
 
Immune-mediated diseases are a group of different pathologies including autoimmune 
diseases affecting around 8% of the population with a predisposition higher for women than 
men. In our study, two diseases recognized as neurological, inflammatory, autoimmune 
disorders were chosen: Multiple Sclerosis (MS) and Rett syndrome (RTT). 
1.1.4 Antigens and antibodies 
 
Antigens (Ags) can be defined as substances that bind to antigen-specific receptors 
(BCRs and TCRs) of the immune system. 
 
There are different types of antigens: 
- Exogenous antigens: these Ags in the body come from outside usually by inhalation, 
ingestion or through the physical barriers. 
- Endogenous antigens: these Ags are generated by the cells through the normal cellular 
metabolism and after bacterial and/or viral infections. 
- Autoantigens: these Ags consist of native peptides or proteins that are recognized as 
targets by the immune system. This is the case of autoimmune diseases. 
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Antibodies (Abs) also known as immunoglobulins (Igs) have an Y-shaped protein, they 
are produced by plasma cells and used by the immune system to identify and neutralize Ags. 
From a structural point of view, antibodies are glycoproteins with two distinct regions: 
- The fragment antigen-binding (Fab) region, which is involved in Ag binding; 
- The fragment crystallizable (Fc) region, which is involved in interactions with 
surfacecell receptors of the immune system. 
There are five different types of Abs, termed isotypes: IgG, IgM, IgA, IgE, and IgD. They 
have different biological properties and functional locations. 
IgGs are the most important isotypes among the five generated by plasma B cells. They 
are present in blood and extracellular fluids and they are the most abundant (~75%) of serum 
immunoglobulins in humans. IgGs are large molecules of about 150kDa and they participate 
in the secondary immune response. IgGs are involved in the regulation of allergic reactions. 
IgG level measurements could be indicative of immune status to pathogens. 
IgM is the largest isotype, it can be found in pentameric forms (~975 kDa), forming a 
“star” of Y-shaped Abs. IgMs are found in blood and consist of the very first response to 
initial exposure to antigens. They are produced by B cells. IgMs have the ability to activate 
the classical pathway of the complement leading to an immune response.  
IgA isotype can be found in mucosal areas in monomeric or dimeric form that is the most 
prevalent. IgAs play a critical role in protection against pathogens. 
IgE antibodies can be found in mucous membranes, lungs, and skin as monomers and are 
synthetized by plasma cells. IgE are the less common isotype of Abs in the organism. They 
have a function in immune response against allergens and parasitic worms.  
IgDs are monomeric antibodies (185kDa) found in very small amounts in blood serum. 
IgD shave important immunological functions such as B cells activation and elimination of B-
lymphocytes, generating self-reactive autoantibodies [2]. 
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1.1 Multiple Sclerosis 
 
Multiple Sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the central 
nervous system (CNS) [4] leading to a variety of sensory and motor disturbances [5]. It is 
characterized by the formation of sclerotic plaques in various areas of the CNS (Figure 3). 
The immune system is responsible to destroy protein components of myelin sheath. These 
plaques are the result of an inflammatory response most likely caused by activation of 
autoimmune Th-1 cell targeting oligodendrocytes and the myelin sheath together with 
activated monocytic cells. These highly immunologically active areas subsequently progress 
to form “scarring” plaques [2].  
 
 
Figure 3: Multiple sclerosis: destruction of the myelin sheath 
http://www.iflscience.com 
 
Symptoms and signs can vary depending on the location and severity of the plaques. 
Generally, motor, sensor, visual, and cognitive disturbances are observed. This disease mostly 
affects women between 20-40 years old with a prevalence of 1/1000 [6]. 
CNS inflammation is the primary cause of the nervous system damage in MS. From a 
mechanistic point of view, MS is considered an inflammatory, multifactorial, autoimmune 
disease in which, genetic and environmental factors must be taken into consideration [4]. 
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An early diagnose of MS is required in order to treat quickly the patients to avoid 
complications and severity of the disease. In the same time, the development of new and more 
specific drugs is in progress in pharmaceutical industries [7]. 
The conventional magnetic resonance imaging (MRI) is the gold standard in clinical 
diagnostics of MS. MRI is also used to follow up disease activity to monitor disease evolution 
[7]. With this technique, inflammation and demyelization can be evaluated. In fact, even if 
extremely expensive and not always available in clinical units, MRI is recognized as a 
diagnostic but also as a prognostic tool to help clinicians in therapeutic decisions [8]. 
It has been suggested that the adaptive immune system drives the early stages of MS 
and the innate immunity drives the progressive stage, although the degree to which the 
adaptive and the innate immune systems affect both stages is uncertain (Figure 4). 
 
Figure 4: Immune status and disease course in MS [9] 
1.2 Rett syndrome 
Rett syndrome (RTT) is a progressive X-linked neurodevelopmental disorder and one 
of the most common causes of mental retardation in females with an estimated prevalence of 
1:10000 to 15000 live births per year [10]. 
The disorder is characterized by a period of normal development during the first 6-18 
months of life followed by gradual loss of skills already gained, such as speech and 
purposeful movement of the hands [11]. RTT girls lose their acquired cognitive, social, and 
motor skills in a typical four-stage neurological regression and develop autistic behavior 
accompanied by stereotypic hand movements. RTT in up to 95% children is mainly caused by 
mutations in the X-linked methyl-CpG-binding protein 2 gene (MeCP2) [12]. MeCP2 protein 
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from the methyl-CpG-binding protein (MBP) family [13] was the first discovered to 
selectively recognize and bind methylated DNA sequences [14]. MeCP2 is a key 
multifunctional protein in the brain (Figure 5) [15]. Hundreds of different MECP2 mutations 
have been associated with Rett syndrome [16] and mutations in other genes were also found. 
 
Figure 5: MeCP2 is a multifunctional protein.  
MeCP2 functions reported so far have been schematically represented. Following a clockwise direction starting 
from the left upper cartoon, MeCP2 can function as a transcriptional repressor that recruits corepressors to 
silence methylated genes; it can mediate the formation of a highly compacted chromatin structure (in a 
methylation independent way); it may play a role in transcriptional activation mainly through its interaction with 
CREB1; it can be involved in mRNA alternative splicing (e.g. through its interactions with YB1) and eventually 
it can influence protein synthesis through modulation of the mTOR pathway [16]. 
 
RTT can be considered as a multi-systemic disease and is a brain pathology that 
includes the unique triad of increased biochemical signs of oxidative stress (OS) derangement 
[17]. 
1.3 Diagnostic methods 
 
AIDs (autoimmune diseases) are a particular class of diseases, with complex 
mechanisms. Some diagnostic methods are available, but each AID is different and there are 
not specific diagnostic methods for each AID. Treatments for autoimmune diseases, when 
available, are extremely expensive and have huge secondary effects on the patients. So, it 
appears crucial to develop diagnostic methods to detect early the presence of the disease. 
12 
 
Most of these methods are based on the detection of inflammatory markers that are usually 
associated with the immune response; or on auto-Abs produced by the immune system [2]. 
 
Multiple Sclerosis is typically diagnosed on the presence of signs and symptoms, in 
combination with supporting MRI and laboratory testing. It can be difficult to confirm, 
especially early the disease. In fact signs and symptoms can be similar to those of other 
medical problems. 
 
The most commonly used tools are neuroimaging and analysis of cerebrospinal fluid. 
Magnetic resonance imaging of the brain can show areas of destruction of the myelin sheat. 
Cerebrospinal fluid obtained by a lumbar puncture can provide evidence of chronic 
inflammation in the central nervous system. The cerebrospinal fluid is tested for oligoclonal 
bands of IgGs by electrophoresis. The oligoclonal bands are inflammation markers found in 
75-85% of people with MS. The nervous system in MS may respond less actively to 
stimulation of the optic nerve and sensory nerves due to demyelization of such pathways. 
 
Rett syndrome is typically diagnosed by a genotype-phenotype analysis to detect 
specific mutation of the X-linked methyl-CpG-binding protein 2 (MeCP2) gene. It can be 
difficult to confirm the diagnosis due to the multi-systemic disorder of RTT where other 
mutations in other genes can be found. Moreover, a series of biochemical processes and 
autoimmune components coexist with the clinical expression of the disease. 
The aim of this PhD is to look for new classes of autoantibodies in patient sera. 
Therefore, we tried to find the best complex glycosidic antigens isolated from plants, 
otherwise difficult to be synthesized, and able to recognise specific antibodies in the case of 
patients affected by multiple sclerosis and rett syndrome. 
Indirect enzyme-linked immunosorbent assays (ELISA) were performed to measure 
IgM levels in sera of patients affected by MS and RTT. 
ELISA is one of the most commonly used immunoassay techniques. It is based on an 
enzyme-labeled antibody capable of detecting a serum antibody specifically recognizing an 
antigen immobilized to a solid surface composed of a 96-well plate. Antigens are coated on 
96-well plate. Then, un-coated areas of the well are blocked using fetal bovine serum (FBS), a 
non-reactive protein solution. After that, diluted patient sera are added allowing the binding of 
the coated Ag to specific Abs present in sera. After whasing the plate, a secondary enzyme-
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coupled Ab is added. Secondary Abs are commonly labeled with alkaline phosphatase. The 
addition of a substrate specific to the secondary enzyme-coupled Ab, can reveal color change 
correlating to the amount of antibodies if present in the original serum sample (Figure 6). 
 
Figure 6: Indirect ELISA procedure  
(http://www.creative-diagnostics.com) 
 
This technique has several advantages: 
- It is a simple and rapid technique to detect antigens attached to a solid surface; 
- A large number of sera can be tested in a very short time; 
- It is a relatively low cost technology. 
ELISA offers commercial value in research laboratories, diagnostics of disease 
biomarkers and quality control in various industries. 
1.4 Research project 
 
Complex glycoconjugates, including glycolipids and glycoproteins, are commonly 
displayed on cell surfaces, where they play crucial role as mediator of extracellular 
communication and signaling networks [18-20]. Therefore, studies on glycan modification 
patterns of glycoconjugates are a great challenge in medical diagnostic research, offering 
insight into cellular and molecular mechanisms. Moreover, glyconjugates can be proposed as 
molecular biomarkers of disease activity and to understand molecular mechanisms of 
immune-mediated diseases [21-22]. Natural glycoconjugates are often complex mixtures of 
closely related materials very difficult to synthetize and analyze. In the field of autoimmunity 
different approaches are used to investigate the structures and functions of complex naturally 
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occurring glycoconjugates leading to the identification of autoantigens associated with 
different autoimmune diseases. In particular, in the context of Multiple Sclerosis and Rett 
syndrome, the identification of serum antibodies as biomarkers to be used for the diagnosis, 
monitoring, and prognosis of such heterogenous disease is a challenge because of the 
ambiguous identification of antigens (Ags) implicated in the disease. 
 
MS pathogenesis has not been yet elucidated. Viral, immunological, and vascular 
hypotheses have been proposed [23]. Most of the putative Ags belongs to myelin protein 
family. Moreover, it is accepted that pathophysiological post-translational modifications of 
native Ags can trigger the immune system to generate autoantibodies escaping conventional 
diagnostic procedures. Thus, autoantibodies against aberrant glycosylations have been 
hypothesized as diagnostic biomarkers of MS [24-25]. In particular, the synthetic N-
glucosylated peptide, a type I’ beta-turn structure termed CSF114(Glc), that was specifically 
designed to detect anti-N-glucosylation disease-specific autoantibodies as biomarkers of MS, 
has been developed as a probe for the detection of autoAbs present in the serum of MS 
patients [26-27]. This probe is able to identify and measure MS-related autoAbs whose levels 
correlated with clinical assessment of MS activity and MRI profile of brain lesion [24]. The 
CSF114(Glc) peptide represents an unconventional approach since its structure is completely 
unrelated to any primary myelin protein structure and is not linked to any particular 
pathogenetic hypothesis. The main characteristic of CSF114(Glc) is its conformational β-turn 
structure exposing the sugar moiety on an asparagine residue, possibly the key element, for 
autoantibody recognition [28-29]. Different synthetic sugar moieties were assembled into the 
amino acid sequence of CSF114 and their reactivity studied in MS patient sera, confirming 
the role of N-glucosylation in autoantibody recognition [30]. Since the human glycoproteome 
repertoire lacks this uniquely modified amino acid, the attention was turned to bacteria, i.e., 
Haemophilus influenzae, expressing cell-surface adhesins including N-Glc, to establish a 
connection between H. influenzae infection and MS. We exploited the biosynthetic machinery 
from the opportunistic pathogen H. influenzae (and the homologous enzymes from A. 
pleuropneumoniae) was exploited to produce a unique set of defined glucosylated adhesin 
proteins. Interestingly we revealed that a hyperglucosylated protein domain, based on the cell-
surface adhesin HMW1A, is preferentially recognized by antibodies from sera of an MS 
patient subpopulation. In conclusion, the hyperglucosylated adhesin is the first example of an 
N-glucosylated native antigen that can be considered a relevant candidate for triggering 
pathogenic antibodies in MS [31]. 
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Rett syndrome (RTT) is an X-linked neurodevelopmental disorder affecting almost 
exclusively women is a multi-systemic disease. Indeed, researchers demonstrated that a single 
monogenic mtutation of methyl-CpG binding protein 2 (MeCP2) is associated with Rett 
syndrome but other gene mutations are also listed. Besides, typical clinical features in 
approximatively 80% of RTT patients can be considered for diagnosis of the disease. An 
increased biochemical sign of oxydative stress derangement can also be observed in case of 
Rett syndrome [17], and recently, in PeptLab at the University of Florence, they hypothesized 
the cohexistence of a perturbation of the immune system in RTT patients. In particular, they 
demonstrated that the N-glucosylated structure based designed peptide CSF114(Glc) was a 
probe also for RTT patients. The IgM levels in RTT patient sera correlated with clinical 
features [32]. Therefore, it was confirmed for the first time the role of N-glucosylation in 
antibody recognition in Rett as first insight of an immune system disruption. 
A previous collaborative study between Florence and Bourgogne Universities on the 
use of pure natural triterpene glycosides as mimetics of native antigens demonstrated that 
saponins tested on multiple sclerosis patient sera displayed a good capacity to recognize IgMs 
(sensivity up to 38%) with a high specificity (88.9%) [33]. 
With these considerations in mind, we could envisage that structures containing 
naturally occurring glycosylations are attractive as possible antigenic probes mimicking 
native glycoconjugates. In particular, saponins are good candidates because their aglycon 
bears various glycosidic moieties, from single sugar to oligosaccharidic chains, as mono or 
bidesmosidic structures. Many of these compounds have been characterized during the last 
decades, and modern techniques of isolation from plants and structural elucidation are now 
available. 
The aim of this PhD project was the selection of isolated natural saponins, i.e., 
triterpene-type saponins, as structures bearing different glycosyl moieties and their 
immunochemical characterization in MS and RTT patient sera in comparison with the 
structure-based designed glycopeptide CSF114(Glc) [34]. 
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Chapter 2: Phytochemical study of five plants 
 
2.1 Botanical study 
 
Five species from three different families were studied: Wisteria frutescens, Wisteria 
floribunda “macrobotrys” and Wisteria floribunda “rosea” from Fabaceae, Weigela florida 
“rumba” from Caprifoliaceae, and Polygala acicularis from Polygalaceae. In this chapter, we 
describe the order, the family and the genus of each studied plant, and finally, the botanical 
characters of each species. 
2.1.1 Fabales order 
 
The Fabales are an order of flowering plants and form part of the nitrogen-fixing 
clade. According to the APG III classification, this order includes the Fabaceae or legumes, 
Quillajaceae, Polygalaceae and Surianaceae families (Figure 7) [35]. The Fabaceae is the 
most important plant family for production of food, containing most of the diversity of the 
Fabales. 
 
Many Fabaceae host bacteria in their roots within structures called nodules. Nitrogen 
fixation is a classic example of a "tendency" or "predisposition". A number of genes involved 
in the establishment of the symbioses with both gram-negative and proteobacteria including 
Rhizobium and the gram-positive actinomycete Frankia, are the same as those involved in 
arbuscular mycorrhizal associations [36]. 
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Figure 7: Phylogeny Fabales order [36]  
 
 
Fabaceae family 
 
The Fabaceae or Leguminosae are dicotyledonous plants belonging to the Fabales 
order. It is a large and important family of flowering plants. It includes trees, shrubs and 
herbaceous plants perennials or annuals. The main distinctive characteristic of this family is 
their fruit [37]. Indeed, according to their constituents (proteins, fat, carbohydrates, vitamins 
and microelements) they have been recognized as nutritive food [38]. 
 
That is why most of them are agricultural and food plants, such as Glycine max 
(Soybean), Phaseolus (beans), Pisum sativum (pea), Cicer arietinum (chickpeas), Medicago 
sativa (alfafa), Arachis hypogaea (peanut), Lathyrus odoratus (sweet pea), Ceratonia siliqua 
(carob), and Glycyrrhiza glabra (liquorice).  
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Wisteria genus 
 
Wisteria Nutt, also called Wistaria Spreng. [39] is a genus of woody vines with 
alternate pinnately compound leaves and a large inflorescence of pendulous, showy purple, 
blue or white flowers. This is very appreciated in horticulture for a garden use. 
Three different species were studied: W. frutescens (the American Wisteria) and two 
cultivars of W. floribunda (japenese Wisteria) “macrobotrys” and “rosea”. 
W. frutescens (L.) Poir. is a toxic plant native to the United States (Figure 8). Its pods, 
seeds, and bark contain toxic principles, a glycoside named wisterin, and a resin. 
 
Figure 8: Wisteria frutescens 
(https://www.jardindupicvert.com)                   (http://www.tropicos.org) 
 
 
W. floribunda (Willd.) DC occurs in Japan and Korea [40-41]. The cultivar “rosea” 
differs mainly by its pink flowers contrary to “macrobotrys” with huge purple and white 
flower grapes, which can measure until one meter (Figure 9). 
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Figure 9: W. floribunda “macrobotrys” and W. Floribunda “rosea” 
(https://www.jardindupicvert.com) 
 
Polygalaceae family 
The Polygalaceae is the major angiosperm group of flowering plants in the Fabales 
order. These plants have a cosmopolite geographic distribution, with around 800 species 
spread over a limited number of 12 to 20 genera [42]. It is mostly composed of herbs, shrubs 
and trees. Under the Cronquist classification system, this family had their own order, 
Polygalales. Currently, according to the APG III classification, the family belongs to Fabales 
[35]. 
 
Polygala genus 
Polygala is the most representative genus of flowering plants from the Polygalaceae 
family. This genus consists of more than 500 species from all over the world of which 39 
species are distributed in China [43]. 
Several species of Polygala were used in traditional medicines as expectorant (P. 
senega, P. tenuifolia P. japonica), tonic and antihepatitis agent (P. fallax). This genus was 
largely studied during the last decades and was reported to contain triterpene glycosides [42]. 
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P. acicularis Oliv. 
Polygala acicularis also known as kikongo of “kienga” was chosen according 
chemotaxonomic criteria. It is used by Bakongo in the Kinshasa region (Badindingi) for 
wounds treatment (Figure 10) [44]. 
 
Figure 10: Polygala acicularis 
 (http://www.tropicos.org)      (https://science.mnhn.fr/) 
 
2.1.2 Dipsacales order 
 
The Dipsacales are an order of flowering plants of dicotyledons. In the APG III system 
of 2009, the order includes only two families, Adoxaceae and Caprifoliaceae (Figure 11) [35]. 
Some well-known members of Dipsacales are Lonicera (honeysuckle), Viburnum and 
Valeriana offinalis. The Dipsacales order is described as higher plants, herbs, vines and 
shrubs [45]. 
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Figure 11: Phylogeny dipsacales order [36] 
 
Caprifoliaceae family 
The Caprifoliaceae family is represented by dicotyledonous flowering plants with 860 
species and 36 genera, with a cosmopolitain distribution. 
They are mostly herbs, perennial or annual, but also creepers or shrubs [45] including 
some ornamental garden plants in temperate regions.  
The flowers have a 4- or 5-lobed calyx, which is usually small, and a 4- or 5-lobed 
corolla which often forms a substantial tube. The lobes may be equal, or formed into two lips 
with 4 lobes for the upper lip and one large lobe for the lower lip. The 4 or 5 stamens attach to 
the tube, alternating with the lobes, with the fruiting portion of the pistil below where the 
calyx and corolla lobes originate. The fruit, usually a fleshy berry, has 2 to 5 seed-forming 
divisions. The leaves are opposite and broad [46]. 
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Weigela genus 
Weigela or Weigelia is a genus of between 7 and 53 species of flowering plants, 
growing to 1-5m tall. All are natives of East Asia. The genus is named after the German 
scientist Christian Ehrenfried Weigel. The flowers of this genus are 2–4 cm long, with a five-
lobed white, pink, or red corolla, which are produced in small corymbs of several together in 
early summer. Concerning the fruit it appears like a dry capsule containing numerous small 
winged seeds [46]. 
Historically, this genus contains ten species from Japan, China, Korea and Manchuria 
but many cultivars were produced [47].  
Weigela florida (Bunge) A. DC. was the first species to be introduced and was widely 
cultivated in the 19
th
 century [46]. It is deciduous shrub that typically grows to 6-10’ tall. For 
our study, the cultivar Weigela florida “rumba”, an ornamental cultivar shrub of medium size 
with pink flowers was chosen according to chemotaxonomic criteria (Figure 12). 
 
 
Figure 12: Weigela florida “rumba” 
(http://www.quebecmultiplants.com) 
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2.2 Previous phytochemical works 
 
After some generalities about the saponins, the triterpene glycosides already isolated 
and described in the literature, from the three genera, Wisteria, Weigela, and Polygala, are 
presented. 
2.2.1 Saponins 
 
Saponins are complex glycosides with a high molecular weight, which have a 
triterpene or steroid skeleton linked with sugar moieties. Saponins are used as detergents and 
they are known to have hemolytic activity [48]. In some cases, saponins can be toxic for 
example for fishes [49]. The majority of saponins are found in food or in medicinal plants. 
The word saponin comes from latin language (“sapo”) and means soap. 
 
Saponins have very interesting pharmacological and biological properties. Researchers 
decided to work on them and in 1987, a lot of new structures have been elucidated thanks to 
new techniques that were developed. Saponins are principally found in higher plants and in 
sea animals such as sea cucumber [50] and sea stars [51] respectively. 
Saponins are complex amphiphilic molecules. They are composed of a lipophilic 
aglycone (or genin) and hydrophilic oligosaccharidic chains linked to the aglycone by an ester 
or an O-heterosidic linkage. The genins are classified in two different groups: steroids and 
triterpenes.  
Triterpenic structure 
- Triterpenic genins are principally found in dicotyledonous Angiosperms as for 
example, in Caryophyllaceae [52] or in Asteraceae family [53]. These genins are 
obtained via cyclisation of the squalen moiety. There are four main types of 
pentacyclic skeletons: oleanane, ursane, lupane and dammarane (Figure 13). 
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Figure 13: Triterpene skeleton: Oleanane (A), dammarane (B), ursane (C) and lupane (D) [54] 
 
Steroidic structure 
- Steroidic genins are principally found in monocotyledonous Angiosperms. There are 
two principal types of skeleton called spirostane and furostane (Figure 14). 
 
 
Figure 14: Steroidic skeleton: spirostane (A) and furostane (B) [54] 
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The genins can be substituted by one or several oligosaccharidic chains. For this 
reason, we can distinguish: 
 
 - Monodesmosidic saponins: they have only one oligosaccharidic chain 
generally linked at the C-3 position of the genin. 
- Bidesmosidic saponins: they have two oligosaccharidic chains linked mainly at the 
C-3 and C-28 position of the genin for triterpenes, and at C-3 and C-26 for steroids. 
- Tridesmosidic saponins: they are very unusual and possess three oligosaccharidic 
chains linked to the genin. 
 
The osidic moieties are generally hexose, desoxy-hexose, ursonic acids and pentose. 
The most common ones found in saponins are presented below in Figure 15. 
 
 
Figure 15: Most common osidic moieties found in saponins 
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Saponins are complex and amphiphilic molecules and it is very difficult to extract and 
purify them, but they have important properties in various fields such as biology, 
pharmacology, food and cosmetics. Moreover, saponins have shown anticarcinogenic, 
antimutagenic, hypoglycemic, hypocholesterolemic, hepatoprotective, immunomodulatory, 
neuroprotective, anticoagulant, anti-inflammatory and antioxidant activities in experimental in 
vivo animal models and in vitro models (Table 1) [55]. 
 
 
Table 1. Health promoting activities of saponins [55] 
 
Saponins are used as emulsifying and foaming agents in cosmetology. Besides, as the 
example of licorice, Glycyrrhiza glabra (Fabaceae), they are traditionally used in the 
treatement of cough. In fact, it is now employed by food industry for its sweetening power 
[54]. 
2.2.2 Isolated saponins from Wisteria genus 
 
From a structural point of view, these molecules are all C-3 monodesmosidic 
oleanane-type glycosides. They possess unusual primary alcohol and carboxyl functions at the 
C-30 position, and a rare ketone function at the C-22 position. The structure of the 
oligosaccharidic chain linked to the C-3 is always the same as Rha-(1-2)-Xyl-(1-2)-GlcA. 
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Soyasaponin II [56] 
 
Wistariasaponin A [57] 
 
Wistariasaponin B1[57] 
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Wistariasaponin B2 [57] 
 
Wistariasaponin C [57] 
 
Astragaloside VIII [58] 
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Robinioside I [58] 
 
Soyasaponin I [58] 
 
Subproside V [58] 
31 
 
 
Wistariasaponin A2 [58] 
 
Wistariasaponin A3 [58] 
 
Wistariasaponin B3 [58] 
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Wistariasaponin YC2 [58] 
 
Wistariasaponin YC1 [58] 
 
Wistariasaponin D [59] 
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Wistariasaponin G [59] 
 
2.2.3 Isolated saponins from Weigela genus 
 
The saponins isolated from Weigela hortensis and W. stelzneri are mono-, 
bidesmosidic oleanolic acid or hederagenin glycosides (Tables 2a and 2b) [47, 60]. 
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Table 2a: Saponins isolated from Weigela genus 
 
 
Table 2b: Saponins isolated from Weigela genus 
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2.2.4 Isolated saponins from Polygala genus 
 
Polygala genus was extensively studied and several species were reported to contain 
triterpene glycosides. Presenegenin, bayogenin, polygalagenin, medicagenic acid, 
hederagenin and preatroxigenin were reported as characteristic aglycons from this genus [42]. 
 
The sequence 3-O-β-D-glucopyranosylpresenegenin 28-O-β-D-xylopyranosyl-(14)-
-L-rhamnopyranosyl-(12)-β-D-fucopyranosyl ester often encountered in these genera, 
represents a chemotaxonomic marker for the Polygalaceae family. During the period 2005-
2012, around sixty triterpene saponins were isolated from several species of the Polygalaceae 
family. From the Polygala genus [43]: 
- From P. ruwenzoriensis, P. arenaria, P. tenuifolia and P. japonica, twenty two are 
presenegenin glycosides; 
- From P. crotalarioides, two with an unusual aglycone, 2-oxo-olean-12-ene-3β, 27-
dihydroxy-23,28-dioic acid; 
- From P. japonica, three having unusual aglycones as 11-oxo-olean12-ene-2β,3β,27-
trihydroxy-23,28-dioic acid, 2-oxo-olean-12-ene-23,28-dioic acid glycoside, 3β,23,27,29-
tetrahydroxy-olean-12-en-28-oic acid, three bayogenin glycosides and three saponin 
derivatives of medicagenic acid; 
- From P. micrantha, three medicagenic acid glycosides were also isolated. 
 Since 2013, new glycosides were isolated from the Polygala genus, mainly from P. 
sibirica and P. flavescens [61-62]. The structures of the isolated compounds are summarized 
in Tables 3a and 3b. 
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Table 3a: Saponins isolated from Polygala genus 
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Table 3b: Saponins isolated from Polygala genus 
 
2.3 Materials and methods 
2.3.1 Phytochemical study 
 
NMR spectra were performed using two different equipments: a Varian INOVA 600 
(Agilent Technologies) at the operating frequency of 600 MHz. The operating conditions 
were as follows: 
1
H: frequency, 600 MHz; sweep width, 8 kHz; sampling point, 66 k; spectral 
width, 7804 Hz, accumulation, 32 pulses; temperature, 304 K. 
13
C: frequency, 150 MHz; 
sweep width, 32 kHz; sampling point, 160 k; spectral width, 30000 Hz, accumulation, 8000 
pulses; temperature, 304 K. Each sample was dissolved in C5D5N (200L) using 5 mm micro-
sample tube (SHIGEMI Co., Ltd., Japan). Chemical shifts were referenced to solvent signal 
(H7.22, C123.87). Conventional pulse sequences were used for gMQF-COSY, TOCSY, 
NOESY, gHSQC, and gHMBC. The mixing time in the NOESY experiment was set to 500 
ms. TOCSY spectra were acquired using the standard MLEV17 spin-locking sequence and 60 
ms mixing time. TOCSY, NOESY and HSQC spectra were recorded using phase-sensitive 
mode. The size of the acquisition data matrix was 2048 x 256 words in f2 and f1, respectively, 
and zero filling up to 2k in f1 was made prior to Fourier transformation. Sine-bell or Shifted 
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sine-bell window functions, with the corresponding shift optimized for every spectrum, were 
used for resolution enhancement and baseline correction was applied in both dimensions. 
 
The second one is a Varian VNMR-S 600 MHz spectrometer equipped with 3 mm 
triple resonance inverse and 3 mm dual broadband probeheads. Spectra are recorded in 
pyridine-d5. Solvent signals were used as internal standard (pyridine-d5: δH = 7.21, δC = 123.5 
ppm), and all spectra were recorded at T = 35°C. The carbon type (CH3, CH2, CH) was 
determined by DEPT and coupling constants (J) were measured in Hz.  
HR-ESIMS (positive-ion mode) was carried out on a Bruker micrOTOF mass 
spectrometer and ESIMS (negative-ion mode) on a Finnigan LCQ Deca. 
Optical rotation values were recorded on an AA-10R automatic polarimeter.  
A R.E.U.S ultrasonic apparatus was used for the extraction. Isolation of compounds 
were carried out using column chromatography (CC) on Sephadex LH-20 (550 mm x 20 mm, 
GE Healthcare Bio-Sciences AB), and vacuum liquid chromatography (VLC) on reversed-
phase RP-18 silica gel (75-200 μm, Silicycle). Medium-pressure liquid chromatography 
(MPLC) was performed on silica gel 60 (Merck, 15-40 μm) with a Gilson M 305 pump (25 
SC head pump, M 805 manometric module), a Büchi glass column (460 mm x 25 mm and 
460 mm x 15 mm), and a Büchi precolumn (110 mm x 15 mm). HPLC was performed on a 
1260 Agilent instrument, equipped with a degasser, a quaternary pump, an autosampler, and 
an UV detector at 210 nm. Chromatographic separation for analytical part was carried out on 
a C18 column (250 mm × 4.6 mm id, 5 μm; Phenomenex LUNA) at room temperature and 
protected by a guard column. The mobile phase constituted of (A) 0.01% (v/v) aqueous 
trifluoroacetic acid and (B) acetonitrile delivered at 1 ml/min according to the gradient. The 
injection volume was 10 µl at the concentration of 1 mg/ml. Semi preparative part: 
Chromatographic separation was carried out on a C-18 column (250 mm x 10 mm id, 5 µm; 
Phenomenex LUNA) at room temperature and protected by a guard column. The gradient was 
the same at 3 ml/min. The injection volume was 0.3 ml at the concentration of 10 mg/ml. 
Thin-layer chromatography (TLC, Silicycle) and high-performance thin-layer 
chromatography (HPTLC, Merck) were carried out on precoated silica gel plates 60F254, 
solvent system CHCl3/MeOH/H2O/AcOH. The spray reagent for saponins was vanillin 
reagent (1% vanillin in EtOH/H2SO4, 50:1). 
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 2.3.1.1 Extraction and plant material 
 
Extractions were performed by an ultrasound-assisted method. Wisteria frutescens 
voucher specimen N° 20111002 was provided in 2011 from Botanic® (Quétigny, France). W. 
floribunda “macrobotrys” voucher specimen N°20151001 and for W. floribunda “rosea” 
voucher specimens, N°20151002 were provided in 2015 from Botanic® (Quétigny, France). 
Weigela florida “rumba” voucher specimen (N° 20121101) was provided in 2012 from 
Jardiland® (Chenôve, France). Each sample was deposited in the herbarium of the Laboratory 
of Pharmacognosy, Université de Bourgogne Franche-Comté, Dijon, France. Polygala 
acicularis was picked up by Pr Delaude from the Liège University (Belgium), in Democratic 
Republic of Congo and was authenticated by Dr Breyne. A sample was deposited in the 
Botanical Laboratory, Université de Louvain, Belgium and in the National Botanical Garden 
of Bruxelles, Belgium.  
 2.3.1.2 Analytic chromatographic methods 
 
At each step of the protocol of purification by chromatographic methods, the 
composition of the obtained fractions is checked by thin layer chromatography. 
Thin layer chromatography (TLC) 
TLC analyses are performed on normal silicagel. The migration is made in glass tanks 
with an appropriate eluent. The mobile phase is usually a mix of three or four solvents. 
Solid support: Normal silica glass plate; (Silica Plate TLC), silicycle Ultra pure silicagel, 10-
12 µm.  
Revelation: Reagent with sulfuric vanillin, heating at 110°C. 
This reagent highlights saponins even if they don’t have UV chromophore groups. 100 
mL of solution composed of 1g vanillin, 2mL sulfuric acid and ethanol 95% is prepared. An 
UV observation at 254nm and 365nm is made before revelation to detect flavonoids or 
compounds with chromophore groups. 
High performance thin layer chromatography (HPTLC) 
The size of the silica gel in HPTLC is thinner than in TLC. These plates are more 
precise. The purity of compounds can be verified by this technique. 
Solid support: HPTLC plate; Merck, type kieselgel 60 F254, 5-6 µm 
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 2.3.1.3 Preparative chromatographic methods 
Vacuum liquid chromatography (VLC) in normal and reversed phase 
The VLC is a chromatographic technique used for preliminary purification. It is 
carried out with a funnel gooch and a vacuum pump. The funnel gooch is full of silica gel 
(normal or reverse phase). The elution can be realized using an isocratic mode or a gradient. 
The polarity of the eluent is chosen according to the polarity of the sample. Before using, 
conditioning is performed with the first solvent of the gradient and the sample is dissolved in 
the same solvent.  
VLC normal phase 
A chloroform/methanol/water eluent is used because of high polarity of the silica gel and the 
amphiphilic nature of the saponins. This step allows to eliminate the tannins and to do a first 
fractionation of the saponins. 
 
Stationary phase: Silicagel 60 (60-200µm) silicycle 
Mobile phase: Isocratic elution by trays with chloroform/methanol/water mixture in different 
proportions (80:20:2, 70:30:5, 60:32:7) 
VLC reverse phase 
A methanol/water mixture is used with this apolar silica gel grafted with hydrophobic groups 
(C-18). This step allows to eliminate free sugars from the crude extract.  
 
Stationary phase: Silicagel RP-18 (75-200µm) silicycle 
Mobile phase: Isocratic elution by trays with methanol/water eluent in different proportions 
Size exclusion chromatography 
This chromatographic method is used to separate compounds according to their 
molecular weight through a dextran gel. The molecules are eluted in the order of their 
decreasing molecular masses. In our case, the order of elution is the following: 
Tannins>Saponins>Flavonoids>Free sugars. 
Stationary phase: Sephadex gel LH-20, GE Healthcare, Biosciences AB 
Mobile phase: methanol 
Column: Glass column 
Collector: Pharmacia Biotech-Super Frac 
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Medium pressure liquid chromatography (MPLC) 
This is a chromatographic technique more precise to purify compounds because of the 
low particle size of the silica gel. A methanol/water mixture is used for reverse phase MPLC 
and a chloroform/methanol/water mixture for normal phase MPLC. The elution is carried out 
with a flow between 2 mL and 5 mL and a maximum pressure of 20 bars. Then, fractions with 
the same chromatographic profile are mixed together and evaporated. 
Stationary phase: silicagel60 F254 (15-40 µm) Merck, or RP-18 (75-200µm) silicycle 
Mobile phase: MeOH/H2O in different proportions (reverse phase) 
              CHCl3/MeOH/H2O in different proportions (normal phase) 
Column: Büchi glass column (230 x 15 mm and 460 x 15 mm) 
Pump: Pump manager C-615, Büchi 
Pump module C-601, Büchi 
Collector: Fraction Collector C-660, Büchi 
High performance liquid chromatography (HPLC) 
This is the most precise chromatographic technique. The problem is the lack of 
chromophores in saponins and so the use of an UV detector at 201nm. 
Analytic column: C18 column (250 mm × 4.6 mm id, 5 μm; Phenomenex LUNA) 
Semi-preparative column: C-18 column (250 mm x 10 mm id, 5 µm; Phenomenex LUNA) 
Mobile phase: 0.01% (v/v) aqueous trifluoroacetic acid and acetonitrile in gradient mode 
Pump: Quaternary pump Büchi® with autosampler an UV detector at 201nm. 
Collector: Büchi® Fraction Collector C-660 
 2.3.1.4 Lyophilisation 
 
This method is based on the sublimation of the water to obtain powder of the product. 
It is dissolved in water, and then frozen before lyophilisation. The resulting powder is easier 
to manipulate and store.  
2.3.2 Structural elucidation 
 2.3.2.1 Mass spectrometry 
 
Mass spectrometry is used to detect and identify molecules with measurements of their 
mass and fragmentation to characterize their structure. The principle is the separation of 
charged molecules in gas phase in function of the mass-to-charge ratio. 
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Electro-Spray Ionization (ESI) 
This technique, very useful for saponins, instead of electronic impact, consists of the 
transfer of ionic species from solution into the gas phase. A continuous stream of the sample 
solution is passed through a capillary tube, which is maintained at a high voltage (e.g. 2.5 - 
6.0 kV). A mixture of highly charged droplets with the same polarity as the capillary voltage 
is generated. A nebulising gas (e.g. nitrogen) is applied. The generated charged droplets pass 
down a pressure and potential gradient toward the analyzer region of the mass spectrometer. 
With an ESI-source temperature and/or another stream of nitrogen drying gas, the charged 
droplets are continuously reduced in size by evaporation of the solvent, leading to an 
increasing charge density at the surface. Finally, the electric field strength within the charged 
droplet reaches a critical point at which it is kinetically and energetically possible for ions at 
the surface of the droplets to be ejected into the gaseous phase. The emitted ions are sampled 
and are then accelerated into the mass analyzer for analysis of molecular mass and 
measurement of ion intensity. (Figure 16) [63]. 
 
Figure 16: Mechanism of electrospray ionization [63] 
 
This technique is sensitive, robust, and reliable to investigate, at femto-mole quantities 
in microliter sample volumes of bio-molecules that couldn’t be analyzed by other 
conventional techniques. 
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 2.3.2.2 Nuclear magnetic resonance (NMR) 
 
The NMR is the most efficient technology to investigate saponin structures. It gives 
informations about the genin, the conformation and configuration of the sugar moieties, the 
interglycosidic linkages, and the position of the sugars on the skeleton. 
 
These informations are obtained with mono- and bi-dimensional spectra. 2D-NMR 
allows to observe correlation between different spins in the molecule. The total assignment of 
the protons and carbons of the saponin can be achieved. 
 
1D- and 2D-NMR spectra HSQC (Heteonuclear Single Quantum Correlation), HMBC 
(Heteonuclear Multiple Bond Correlation), COSY (COrrelated SpectroscopY), TOCSY (Total 
Correlation SpectroscopY), and NOESY (Nuclear Overhauser Effect SpectroscopY) or 
ROESY (Rotating-frame Overhauser Effect SpectroscopY), are performed for each molecule. 
Measurements are made in pyridine d5 (C5D5N) and chemical shifts δ are expressed in ppm. 
  2.3.2.2.1 1D NMR: 1H and 13C NMR spectra 
 
1
H NMR and 
13 
C NMR spectra revealed mainly the signals of methyls, methylenes 
and methines of the aglycon, double bonds, and osidic groups with their anomeric position.  
With NMR 
13
C spectra register in DEPT (Distortionless Enhanced Polarization 
Transfer), primary and tertiary carbons can be differentiated from secondary.  
 
  2.3.2.2.2 2D NMR: Homo- and heteronuclear correlations 
 
Heteronuclear correlations 
1
H/
13
C 
 
HSQC: This experiment allows to see a direct coupling (
1
J) between carbon and proton.   
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HMBC: It is an experiment to see long-range heteronuclear coupling 
1
H/
13
C (
2
J and 
3
J). It is 
essential to determine the structure of aglycon, sugar moieties, interglycosidic linkages and 
skeleton/oligosaccharidic chain linkages. 
 
 
Homonuclear correlations 
 
COSY: Homonuclear 
2
J and 
3
J coupling between two protons in the same spin system is used 
to see neighbor protons in the molecule.  
 
 
TOCSY: This experiment also called HOHAHA (HOmonuclear HArtmann-HAhn 
spectroscopy) is very usefull to see protons in the same spin system. We can see all protons in 
one sugar. 
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NOESY: It is an experiment, which shows dipolar interactions for protons separated by less 
than 3,5 Å. With NOESY spectra spatial proximity can be found for some part of the 
molecule. It’s very useful to determine linkage between different parts of the molecule. The 
ROESY spectrum can be also used. 
 
 
2.4 Personal works 
 
 2.4.1 Extraction and isolation 
 
W. frutescens 
 
The roots of W. frutescens were studied. Six triterpene glycosides (1-6) were isolated 
using various chromatographic methods: two previously undescribed, one described in its 
native form for the first time, and three known ones already reported in the literature. 
Extraction and isolation of these compounds are summarized below:  
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W. floribunda “macrobotrys” 
The roots of W. floribunda “macrobotrys” were analysed. Three saponins (7-9) were 
extracted and purified: one new oleanane-type glycoside and two known ones: 
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W. floribunda “rosea” 
The roots of W. floribunda “rosea” were extracted. Two known saponins (10, 11) were 
obtained by chromatographic methods: 
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W. Florida “rumba” 
From the roots of W. florida “rumba”, three new saponins (12-14) were isolated. 
Extraction and isolation are presented: 
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Polygala acicularis 
From the roots of Polygala acicularis two presenegenin glycosides (15, 16) previously 
described in literatue were isolated. The protocol is described below: 
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2.4.2 Structural elucidation 
 
W. frutescens 
 
Six oleanane-type saponins from the roots of W. frutescens were isolated. Their 
structures were established by a detailed 600 MHz NMR analysis including 1D and 2D NMR 
(
1
H, 
13
C NMR, COSY, TOCSY, NOESY, HSQC, HMBC) experiments and mass 
spectrometry as two previously undescribed triterpenoid saponins (1, 2) and four known ones 
(3-6). The structural analysis of the native form of wistariasaponin G (3) is described for the 
first time. 
 
The saponins 1-3 were isolated from an aqueous-ethanolic extract of the roots of W. 
frutescens by various solid/liquid chromatographic methods: vacuum liquid chromatography 
(VLC) on normal and reverse phase RP-18 silica gel, medium pressure liquid chromatography 
(MPLC) and size exclusion chromatography on Sephadex LH-20. 
 
The HR-ESIMS (positive-ion mode) spectrum of compound 1 established its 
molecular formula as C51H80O20 with a pseudo-molecular peak at m/z 1035.5150 [M + Na]
+
 
(calcd 1035.5141). Its ESIMS (negative-ion mode) displayed a quasi-molecular ion peak at 
m/z 1011 [M – H]–, indicating a molecular weight of 1012 (Figure 17).  
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Figure 17: Positive ESIMS of saponin 1 
 
The 
1
H NMR spectrum of the aglycone part of 1 displayed signals assignable to seven 
angular methyl groups at H 0.75, 0.85, 0.98, 1.01, 1.07, 1.22 and 1.28 (3H s, each), one 
olefinic proton at H 5.28 (1H, br t, J = 3.0, H-12), three oxygen bearing methine protons at H 
3.23 (1H, dd, J = 12.0, 3.8 Hz, H-3ax), 4.53 (1H, dd, J = 12.4, 4.0 Hz, H-16ax) and 6.10 (1H, 
br s, H-22eq), and one primary alcoholic function at H 4.23 (1H, d, J = 12.4 Hz, H-28aeq), 
4.86 (1H, d, J = 12.4 Hz, H-28beq) (Table 4). In the 
13
C NMR spectrum, signals at C 170.3 
and 171.1 suggested two ester functions. Furthemore, HMBC correlations at H 2.01 (3H, s) / 
C 171.1 and H 2.09 (3H, s) / C 170.3 revealed the presence of two acetyl groups. A HMBC 
cross-peak at H 1.65 (1H, dd, J = 13.3, 4.0 Hz, H-15eq) / C 141.7 (C-13) and a COSY 
correlation between H 1.65 (1H, dd, J = 13.3, 4.0 Hz, H-15eq), 2.24 (1H, dd, J = 13.3, 12.4 
Hz, H-15ax) and 4.53 (1H, dd, J = 12.4, 4.0 Hz, H-16ax), allowed the location of a secondary 
alcoholic function at the C-16 position. A HMBC correlation between a deshielded signal 
atH 4.23 (1H, d, J = 12.4 Hz, H-28aeq) and C 66.4 (C-16) proved the location of the primary 
alcoholic function at C-28. Other HMBC correlations of H 1.07 (3H, s, H3-30ax) and 0.85 
(3H, s, H3-29eq) with C 37.7 (C-21), and a COSY correlation between H 1.74 (H-21ax) and 
6.10 (1H, br s, H-22eq) confirmed the location of another secondary alcoholic function at C-
22. The configurations of C-3 and C-16 of the aglycone were determined by the correlations 
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observed in the NOESY spectrum between H-3 -axial and H3-23 -equatorial, and between 
H-16 -axial and H3-27 -axial, respectively. The -equatorial orientation of H-22 was 
deduced by its coupling constant as a br s and by the NOESY connectivity with -axial H-16. 
The structure of the aglycone of 1 was thus recognized to be the unusual olean-12-ene-
3,16,22-28-tetrol, a stereoisomer of the camelliagenin A (Table 4). The deshielded values 
of H-22eq at H 6.10 and H-28aeq and H-28beq at H 4.23, 4.86, respectively, suggested an 
acetylation at these two positions (Table 4, Figure 18). The HMBC correlation between H 
4.23 (H-28aeq) and C 171.1 (OCO) allowed the location of the first acetyl group at C-28 and 
thus the location of the other acetyl group at C-22. 
 
 
Figure 18: Significant NOE correlations in NOESY experiment of compound 1. 
 
The HSQC spectrum of 1 displayed signals of three anomers atH 5.53 (1H, d, J = 7.3 
Hz) / C 102.1, H 4.83 (1H, d, J = 6.9 Hz) / C 104.8, and H 6.20 (1H, br s) / C 101.6 
(Figures 19, 20 and 21). The ring protons of the monosaccharide residues were assigned 
starting from the readily identifiable anomeric protons by means of the 
1
H-
1
H COSY, 
TOCSY, HSQC, and HMBC experiments and by GC (see experimental). Units of one -D-
glucuronopyranosyl (GlcA), one -D-xylopyranosyl (Xyl), and one-L-rhamnopyranosyl 
(Rha) were thus identified (Table 5). The monodesmosidic structure was suggested by the 
HMBC cross-peak at H 4.83 (1H, d, J = 6.9 Hz, GlcA-1) / C 89.6 (C-3) and the NOESY 
cross-peak at H 4.83 (1H, d, J = 6.9 Hz, GlcA-1) / H 3.23 (1H, dd, J = 12.0, 3.8 Hz, H-3ax) 
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(Figure 22). Other HMBC correlations at H 4.23 (1H, dd, J = 8.0, 6.9 Hz, GlcA-2) / C 102.1 
(Xyl-1) and at H 4.14 (1H, dd, J = 8.8, 7.3 Hz, Xyl-2) / C 101.6 (Rha-1) suggested a -L-
rhamnopyranosyl-(12)--D-xylopyranosyl-(12)--D-glucuronopyranosyl sequence (Table 
5). 
 
Figure 19: General HSQC of saponin 1 
 
Figure 20: HSQC anomers zone of saponin 1 
57 
 
 
Figure 21: HSQC spectrum of saponin 1 
 
Figure 22: ROESY spectrum of saponin 1 
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The monosaccharides obtained by acid hydrolysis of 1 were identified by comparison 
on TLC with authentic samples as glucuronic acid, xylose and rhamnose. The absolute 
configurations of the sugars were determined to be D for GlcA and Xyl, and L for Rha by GC 
analysis according to a method previously described [64]. The large 
1
JH-1,C-1 value of the Rha 
(167 Hz) confirmed that the anomeric proton was equatorial (-pyranoid anomeric form). The 
relatively large 
3
JH-1,H-2 value of GlcA and Xyl (6.9 and 7.3 Hz, respectively) in their pyranose 
form indicated their  anomeric orientation. The same protocol was used for the identification 
of the monosaccharides of 2 and 3. 
 
On the basis of the above results, the structure of 1 was elucidated as the new 3-O--
L-rhamnopyranosyl-(12)--D-xylopyranosyl-(12)--D-glucuronopyranosyl-22,28-O-
diacetylolean-12-ene-3,16,22,28-tetrol (1). 
 
The HR-ESIMS (positive-ion mode) spectrum of compound 2 showed a pseudo-
molecular ion peak at m/z 1023.5269 [M + Na]
+
 (calcd 1023.5141) ascribable to the molecular 
formula C50H80O20. Its ESIMS (positive-ion mode) displayed a quasi-molecular ion peak at 
m/z 1023 [M + Na]
+
, indicating a molecular weight of 1000 (Figure 23).  
 
 
Figure 23: Positive ESIMS of saponin 2 
 
The 
1
H NMR spectrum of the aglycone part of 2 displayed signals assignable to seven 
angular methyl groups at H 0.74, 0.83, 0.92, 1.01, 1.03, 1.22 and 1.28 (3H, s, each), one 
olefinic proton at H 5.22 (1H, br t, J = 3.1, H-12), three oxygen bearing methine protons at H 
3.21 (1H, dd, J = 11.9, 3.6 Hz, H-3ax), 4.53 (1H, dd, J = 12.5, 4.1 Hz, H-16ax) and 6.24 (1H, 
br s, H-22eq), and one free primary alcoholic function at H 4.25 (1H, d, J = 12.3 Hz, H-28aeq), 
4.93 (1H, d, J = 12.3 Hz H-28beq) / C 63.0. In the 
13
C NMR spectrum, a signal at C 170.2 
suggested an ester function and a HSQC correlation at H 2.07 (3H, s) / C 21.0 revealed the 
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presence of only one acetyl group. These signals suggested that the aglycone of 2 is a 22-O-
acetylated derivative of the aglycone of 1 (Table 4). 
 
The HSQC spectrum of 2 displayed signals of three anomers atH 4.81 (1H, d, J = 7.1 
Hz) / C 104.8, 5.50 (1H, d, J = 7.4 Hz) / C 101.9, and 6.18 (1H, br s) / C 101.6. According 
to the same protocol as for compound 1, units of one -D-glucuronopyranosyl, one -D-
glucopyranosyl, and one-L-rhamnopyranosyl were identified (Table 5, Figures 24 and 25). 
NOESY correlations were mainly used to establish the structure of the oligosaccharidic chain, 
between H 4.81 (1H, d, J = 7.1 Hz, GlcA-1) / H 3.21 (1H, dd, J = 11.9, 3.6 Hz, H-3ax), H 
5.50 (1H, d, J = 7.4 Hz, Glc-1) / H 4.44 (1H, dd, J = 8.1, 7.1 Hz, GlcA-2), and H 6.18 (1H, 
br s, Rha-1) / H 4.12 (1H, dd, J = 8.4, 7.4 Hz Glc-2) (Figure 26).  
 
 
Figure 24: General HSQC spectrum of saponin 2 
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Figure 25: HSQC anomers zone of saponin 2 
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Figure 26: NOESY spectrum of saponin 2 
 
The structure of the new natural compound 2 was thus established as 3-O--L-
rhamnopyranosyl-(12)--D-glucopyranosyl-(12)--D-glucuronopyranosyl-22-O-
acetylolean-12-ene-3,16,22,28-tetrol (2). 
 
The HR-ESIMS (positive-ion mode) spectrum of compound 3 established its 
molecular formula as C49H76O20 with a pseudo-molecular peak at m/z 1007.4881 [M + Na]
+
 
(calcd 1007.4828). Its ESIMS (positive-ion mode) displayed a quasi-molecular ion peak at 
m/z 1007 [M + Na]
+
, indicating a molecular weight of 984 (Figure 27). 
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Figure 27: Positive ESIMS of saponin 3 
 
The NMR signals of compound 3 sugar portion were superimposable to those of 1 
(Table 4). Moreover, the oligosaccharidic chain 3-O--L-rhamnopyranosyl-(12)--D-
xylopyranosyl-(12)--D-glucuronopyranosyl was linked at the C-3 position of the aglycone 
according to the NOESY cross-peak at H 3.37 (1H, dd, J = 12.0, 3.7 Hz H-3ax) / H 4.79 (1H, 
d, J = 6.9 Hz, GlcA-1) (Figures 28, 29, 30 and 31) . The 
1
H NMR spectrum area 
corresponding to the aglycone part of 3 showed six tertiary methyl groups as singlets at H 
0.59, 0.83, 0.91, 1.23, 1.26, 1.39, (3H, s, each), one olefinic proton at H 5.46 (1H, br t, J = 
3.0 Hz, H-12), three oxygen bearing methine protons at H 3.37 (1H, dd, J = 12.0, 3.7 Hz H-
3ax) and 4.77 (1H, br s, H-22eq), and one free primary alcoholic function at H 3.35 (1H, d, J = 
11.2 Hz, H-24aax), 4.20 (H-24bax) / C 62.6. In the 
13
C NMR spectrum, a signal at C 180.5 
suggested a free carboxylic acid group and another signal at C 170.9, an ester function. The 
HSQC correlation at H 2.09 (3H, s) / C 21.1 confirmed the presence of one acetyl group.  
 
A HMBC correlation between H 0.91 (3H, s, H3-28eq) and C 78.1 (C-22) allowed the 
location of one secondary alcoholic function at C-22. The deshielded value of the C-22 signal 
was in accordance with an acetylation as described in the previous compounds 1 and 2. In the 
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same way, a HMBC cross-peak at H 1.39 (3H, s, H3-23eq) and C 62.6 (C-24) placed the 
primary alcoholic function at the C-24 position. NOESY correlations between H3-23 -
equatorial and H-3 -axial and H-5 -axial confirmed the location of the CH2OH group at the 
24 -axial position. The configuration of C-22 was determined by the connectivity observed 
in the NOESY spectrum between H-22 -equatorial and H3-27 -axial. The lack of NOESY 
correlations between H3-30ax and H-18ax and H3-28eq suggested the location of the 
carboxylic acid group at the C-30 position. The structure of the aglycone was thus recognized 
as an acetylated derivative of the 3,22,24-trihydroxyolean-12-en-30-oic acid (Table 4).  
 
 
Figure 28: General HSQC of saponin 3 
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Figure 29: HSQC anomers zone of saponin 3 
 
Figure 30: HSQC spectrum of saponin 3 
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Figure 31: ROESY spectrum of saponin 3 
On the basis of these results and the literature data, the structure of compound 3 was 
elucidated as 3-O--L-rhamnopyranosyl-(12)--D-xylopyranosyl-(12)--D-
glucuronopyranosyl-22-O-acetyl-3,22,24-trihydroxyolean-12-en-30-oic acid (3). This 
saponin, named wistariasaponin G, was already isolated from Wisteria brachybotrys but its 
structural analysis was performed after methylation. For the first time, we have described the 
structural elucidation of its native form.  
 
After 1D and 2D NMR analysis, structures of 1-3 were elucidated as: 3-O--L-
rhamnopyranosyl-(12)--D-xylopyranosyl-(12)--D-glucuronopyranosyl-22,28-O-
diacetylolean-12-ene-3,16,22,28-tetrol (1), 3-O--L-rhamnopyranosyl-(12)--D-
glucopyranosyl-(12)--D-glucuronopyranosyl-22-O-acetylolean-12-ene-3,16,22,28-
tetrol (2) and 3-O--L-rhamnopyranosyl-(12)--D-xylopyranosyl-(12)--D-
glucuronopyranosyl-22-O-acetyl-3,22,24-trihydroxyolean-12-en-30-oic acid (3) (Figure 
32) and three known oleanane-type glycosides were identified as:  3-O--L-rhamnopyranosyl-
(12)--D-xylopyranosyl-(12)--D-glucuronopyranosyl wistariasapogenol A 
(wistariasaponin A) (4) [56], 3-O--L-rhamnopyranosyl-(12)--D-xylopyranosyl-(12)--
D-glucuronopyranosyl soyasapogenol B (wistariasaponin C) (5) [56], and 3-O--L-
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rhamnopyranosyl-(12)--D-glucopyranosyl-(12)--D-glucuronopyranosyl soyasapogenol 
B (azukisaponin V) (6) [65] (Figure 33). 
 
Table 4. 
13
C NMR and 
1
H NMR data of the aglycones of compounds 1-3 in Pyridine-d5/D2O ( ppm, J 
in Hz) 
 1 2 3 
Position C H  C H   C H  
1 38.6 0.82 (1H, m) 
1.34 (1H, m) 
38.7 0.78 (1H, m)  
1.33 (1H, m) 
38.5 0.79 (1H, m) 
1.29 (1H, m) 
2 26.1 1.81 (1H, m) 
 2.33 (1H, m) 
26.1 1.92 (1H, m)  
2.25 (1H, m) 
26.2 1.86 (1H, m) 
2.45 (1H, m) 
3 89.6 3.23 (1H, dd, 12.0, 3.8) 90.6 3.21 (1H, dd, 11.9, 3.6) 90.9 3.37 (1H, dd, 12.0, 3.7)  
4 39.4 - 39.4 - 43.7 - 
5 55.5 0.67 (1H, br d, 10.8) 55.5 0.65 (1H, br d, 10.5) 55.9 0.79 (1H, br d, 10.8) 
6 18.3 1.22 (1H, m)  
1.39 (1H, m) 
18.2 1.18 (1H, m) 
1.39 (1H, m) 
18.4 1.21 (1H, m) 
1.52 (1H, m) 
7 32.3 1.20 (1H, m)  
1.40 (1H, m) 
32.8 1.20 (1H, m)  
1.40 (1H, m) 
32.5 1.17 (1H, m)  
1.38 (1H, m) 
8 40.0 - 39.9 - 39.8 - 
9 47.3 1.46 (1H, dd, 14.0, 7.0) 47.0 1.46 (1H, dd, 14.0, 6.9) 47.3 1.48 (1H, dd, 13.9, 6.8) 
10 36.3 - 36.5 - 36.1 - 
11 23.5 1.66 (1H, m)  
1.75 (1H, m) 
23.8 1.70 (1H, m) 
1.74 (1H, m) 
23.7 1.62 (1H, m)  
1.68 (1H, m) 
12 123.3 5.28 (1H, br t, 3.0) 122.3 5.22 (1H, br t, 3.1) 123.1 5.46 (1H, br t, 3.0) 
13 141.7 - 141.5 - 144.5 - 
14 42.8 - 43.1 - 41.7 - 
15 36.5 1.65 (1H, dd, 13.3, 4.0) 
2.24 (1H, dd, 13.3, 12.4) 
37.0 1.72 (1H, dd, 13.4, 4.1)  
2.17 (1H, dd, 13.4, 12.5) 
25.9 1.70 (1H, m) 
1.88 (1H, m) 
16 66.4 4.53 (1H, dd, 12.4, 4.0) 68.0 4.53 (1H, dd, 12.5, 4.1) 26.2 0.96 (1H, m)  
1.80 (1H, m) 
17 46.7 - 46.2 - 36.0 - 
18 43.1 2.57 (1H, dd, 13.4, 3.4) 42.2 2.38 (1H, dd, 13.0, 3.0) 44.5 2.84 (1H, dd, 12.8, 3.6) 
19 45.8 1.18 (1H, dd, 13.6, 3.4) 46.3 1.16 (1H, dd, 13.3, 3.0) 41.7 1.72 (1H, dd, 13.2, 3.6) 
  1.91 (1H, dd, 13.6, 13.4)  1.86 (1H, dd, 13.3, 13.0)  2.30 (1H, dd, 13.2, 12.8) 
20 29.9 - 30.0 - 43.7 - 
21 37.7 1.74 (overlapped) 
2.86 (1H, br d, 13.6) 
37.6 1.75 (overlapped) 
2.90 (1H, br d, 14.0) 
35.2 
 
1.63 (overlapped) 
2.81 (1H, br d, 13.6) 
22 71.3 6.10 (1H, br s) 70.2 6.24 (1H, br s) 78.1 4.77 (1H, br s) 
23 27.9 1.22 (3H, s) 28.0 1.22 (3H, s) 22.5 1.39 (3H, s) 
24 16.7 0.98 (3H, s) 16.2 1.01 (3H, s)  
 
62.6 3.35 (1H, d, 11.2) 
4.20 (overlapped) 
25 15.2 0.75 (3H, s) 15.1 0.74 (3H, s) 15.2 0.59 (3H, s) 
26 16.7 1.01 (3H, s) 16.3 0.92 (3H, s) 16.5 0.83 (3H, s) 
27 27.3 1.28 (3H, s) 27.2 1.28 (3H, s) 26.3 1.23 (3H, s) 
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28 64.7 4.23 (1H, d, 12.4) 
4.86 (1H, d, 12.4) 
63.0 4.25 (1H, d, 12.3) 
4.93 (1H, d, 12.3) 
21.1 0.91 (3H, s) 
29 33.4 0.85 (3H, s) 34.0 0.83 (3H, s) 29.9 1.26 (3H, s) 
30 26.9 1.07 (3H, s) 27.9 1.03 (3H, s) 180.5  
at C-22 
CH3CO 
      
COCH3 170.3  170.2  170.9  
CH3CO 21.1 2.09 (3H, s) 21.0 2.07 (3H, s) 21.1 2.09 (3H, s) 
at C-28       
COCH3 171.1      
CH3CO 20.9 2.01 (3H, s)     
 
 
Table 5. 
13
C NMR and 
1
H NMR data of the sugar moieties of compounds 1-3 in Pyridine-d5/D2O ( ppm, J 
in Hz) 
 1 2 3 
Position C H   C H   C H  
GlcA-1 104.8 4.83 (1H, d, 6.9) 104.8 4.81 (1H, d, 7.1) 104.7 4.79 (1H, d, 6.9) 
2 78.4 4.23 (1H, dd, 8.0, 6.9) 77.8 4.44 (1H, dd, 8.1, 7.1) 77.3 4.17 (1H, dd, 8.1, 6.9) 
3 75.7 4.22 overlapped 75.9 4.22 (1H, dd, 8.1, 7.0) 75.7 4.22 overlapped 
4 73.8 4.12 (1H, dd, 8.3, 6.9) 73.5 4.10 (1H, dd, 8.3, 7.0) 73.7 4.13 (1H, dd, 8.3, 6.9) 
5 78.4 4.44 (1H, d, 8.3) 78.0 4.42 (1H, d, 8.3) 77.8 4.42 (1H, d, 8.3) 
6 172.7 - 173.0 - 172.8 - 
Xyl-1 102.1 5.53 (1H, d, 7.3)   102.2 5.42 (1H, d, 7.4) 
2 77.5 4.14 (1H, dd, 8.8, 7.3)   78.4 4.19 (1H, dd, 8.5, 7.4) 
3 78.7 4.07 (1H, dd, 8.8, 7.6)   78.8 3.99 (1H, dd, 8.5, 6.9) 
4 70.5 4.31 m   70.3 4.31 m 
5 66.3 3.47 (1H, dd, 11.2, 10.2) 
4.24 (1H, dd, 11.2, 5.3) 
  66.3 3.38 (1H, dd, 11.9, 9.5) 
4.29 (1H, dd, 11.9, 5.2) 
Glc-1   101.9 5.50 (1H, d, 7.4)   
2   78.1 4.12 (1H, dd, 8.4, 7.4)   
3   78.2 4.08 (1H, t, 9.1)   
4   70.6 4.28 (1H, t, 9.0)   
5   77.4 3.80 m   
6   62.6 4.05 (1H, dd, 10.5, 4.5) 
4.52 (1H, dd, 10.5, 1.7) 
  
Rha-1 101.6 6.20 (1H, br s) 101.6 6.18 (1H, br s) 101.7 6.14 (1H, br s) 
2 71.8 4.66 (1H, br s) 72.0 4.68 (1H, br s) 71.8 4.67 (1H, br s) 
3 71.9 4.63 (1H, dd, 9.2, 2.5) 72.0 4.62 (1H, dd, 9.0, 2.5) 71.9 4.61 (1H, dd, 9.1, 2.4) 
4 73.8 4.27 (1H, t, 9.2) 73.8 4.26 (1H, t, 9.0) 73.3 4.27 (1H, t, 9.1) 
5 69.1 4.91 (1H, dq, 9.2, 6.6) 69.0 4.95 (1H, dq, 9.0, 6.2) 68.9 4.92 (1H, dq, 9.1, 6.0) 
6 18.5 1.71 (1H, d, 6.6) 18.0 1.70 (1H, d, 6.2) 18.4 1.72 (1H, d, 6.0) 
Overlapped proton signals are reported without designated multiplicity. 
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Figure 32: Structure of saponins 1-3 
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Figure 33: Structure of saponins 4-6 
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W. floribunda “macrobotrys” and “rosea” 
From the roots of W. floribunda “macrobotrys”, a previously undescribed saponin (7) 
was isolated, together with two known ones (8, 9), and its structure was elucidated. From the 
roots of W. floribunda“rosea”, two known ones were identified (10, 11). 
The HR-ESIMS (positive-ion mode) of 7 established its molecular formula as 
C43H66O16 with a pseudo-molecular ion peak at m/z 861.4268 [M + Na]
+
 (calcd 861.4249). Its 
ESIMS (negative-ion mode) displayed a quasi-molecular ion peak at m/z 837 [M – H]–, 
indicating a molecular weight of 838 (Figure 34). 
 
Figure 34: Negative ESIMS of saponin 7 
 
The 
1
H NMR spectrum of the aglycon part displayed signals assignable to six angular 
methyl groups as singlets at δH 0.82 (H3-25), 0.91 (H3-26), 0.93 (H3-28), 1.26 (H3-27), 1.27 
(H3-29), 1.36 (H3-23), one olefinic proton at δH 5.46 (br t, J = 3,0 Hz) (H-12), two oxygen-
bearing methine protons at δH 3.46 (H-3) and 4.75 (br s) (H-22), and one primary alcoholic 
function at δH 3.48 (d, J = 11.2 Hz), 4.25 (d, J = 11.2 Hz) (H2-24) (Table 7). A signal in the 
13
C NMR spectrum at δC 179.2 suggested a carbonyl function of a free carboxylic acid group. 
Another one at δC 170.2 suggested a carbonyl function of an acetyl group, which was 
confirmed by a HMBC cross-peak at δH 2.07 (s)/ δC170.2, and a HSQC correlation at δH 2.07 
(s)/ δC 21.1.The HMBC correlation between an angular methyl group at δH 1.36 (s, H3-23) and 
δC 89.9 (C-3), allowed the location of the first secondary alcoholic function at C-3.  
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The second one was located at C-22, by observation of a HMBC correlation at δH 0.93 
(s, H-28)/ δC 77.8 (C-22). The deshielded chemical shift of H-22 at δH 4.75 suggested an 
acetylation at the C-22 position. In the HMBC spectrum, a cross-peak between δH 1.36 (H3-
23) and δC 62.7 (C-24) allowed the location of the primary alcoholic function at C-24 
position. More correlations were observed between δH 1.27 (s, H3-29), 1.74 (dd, J = 13.6, 3.0, 
H-21), and 1.79 (dd, J = 13.5, 3.4, H-19), and δC 179.2, to find the location of the free 
carboxylic group at the C-30 position. The lack of ROESY correlations between H3-30βax and 
H-18βax and H3-28βeq suggested the location of the carboxylic acid group at the C-30 position. 
The configuration of C-3 was determined by the interactions observed in the ROESY 
spectrum between H-3 α -axial and H3-23 α-equatorial. Moreover, the multiplicity of the H-22 
at δH 4.75 as a (br s), confirmed the α-equatorial orientation of the H-22.  
The structure of the aglycon of 7 was thus recognized to be the 22-O-acetyl-3β, 22β, 
24-trihydroxyolean-12-en-30-oic acid, previously described in W. frutescens [66], W. 
brachybotrys [56-59] and Millettia speciosa Champ. Ex Benth. [67] (Table 7, Figure 35). 
 
Figure 35: Key HMBC and ROESY correlations for the aglycon of 7. 
In the osidic region, the HSQC spectrum of 7 displayed two anomeric signals at δH 
4.77 (1H, d, J = 7.6 Hz)/ δC 104.3 and δH 5.21 (d, J = 6.9 Hz)/ δC 105.2 (Figure 36, 37 and 
38). The ring protons of the monosaccharide residues were assigned starting from the readily 
identifiable anomeric protons by means of the 
1
H-
1
H COSY, TOCSY, HSQC, and HMBC 
experiments. The monosaccharides obtained by acid hydrolysis of 7 were identified by 
comparison on TLC with authentic samples as glucuronicacid (GlcA) and xylose (Xyl). The 
absolute configurations of the sugars were determined to be D for GlcA and Xyl by GC 
analysis according to a method previously described. The relatively large 
3
JH-1,H-2 value of the 
GlcA and Xyl (7.6, 6.9 Hz) in their pyranose form indicated a β anomeric orientation for 
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GlcA and Xyl. Units of one β-D-glucuronopyranosyl and one β-D-xylopyranosyl were thus 
identified (Table 6). The 3-O-heterosidic linkage was suggested by a HMBC cross-peak δH 
4.77 (d, J = 7.6 Hz, GlcA-1)/ δC 89.9 (C-3), and a ROESY cross-peak at δH 4.77 (GlcA-1)/ δH 
3.46 (H-3). The HMBC correlations at δH 5.21 (d, J = 6.9 Hz, Xyl-1)/ δC 81.1 (GlcA-2) and 
the ROESY correlation at δH 5.21 (Xyl-1)/ δH 4.00 (dd, J = 8.4, 7.6, GlcA-2) proved a β-D-
xylopyranosyl-(12)- β-D-glucuronopyranosyl sequence (Table 6, Figure 39). 
 
 
 
 
Figure 36: General HSQC of saponin 7 
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Figure 37: HSQC anomers zone of saponin 7 
 
Figure 38: HSQC spectrum of saponin 7 
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Figure 39: HMBC spectrum of saponin 7 
 
On the basis of the above results, the structure of 7 was elucidated as 3-O-β-D-
xylopyranosyl-(12)-β-D-glucuronopyranosyl-22-O-acetyl-3β,22β,24-trihydroxyolean-12-
en-30-oic acid (7) (Figure 40). 
 
From W. floribunda“macrobotrys”, the known molecules were already isolated from 
W. frutescens [66] as 3-O-α-L-rhamnopyranosyl-(12)-β-D-xylopyranosyl-(12)- β -D-
glucuronopyranosyl-22-O-acetyl-3β,22 β,24-trihydroxyolean-12-en-30-oic acid (8), and 3-O- 
α -L-rhamnopyranosyl-(12)-β-D-xylopyranosyl-(12)-β-D-glucuronopyranosyl-22,28-O-
diacetylolean-12-ene-3 β,16 β,22 β,28-tetrol (9). From the roots of W. floribunda“rosea”, the 
two known saponins were identified as 3-O-α-L-rhamnopyranosyl-(12)-β-D-xylopyranosyl-
(12)-β-D-glucuronopyranosyl-olean-12-ene-3 β,22 β,24-triol (10) (Astragaloside VIII) [68], 
and 3-O-α-L-rhamnopyranosyl-(12)-β-D-galactopyranosyl-(12)-β-D-glucuronopyranosyl-
22-O-acetyl-3β,22 β,24-trihydroxyolean-12-en-30-oic acid (11) (Millettiasaponin A) [67] 
(Figure 40).  
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A literature survey of other Wisteria species [56-59, 66] and other genera of the 
Fabaceae [69] such as Astragalus L. [70-72], Glycine Willd. [73] or Medicago L. [74] for 
example, showed that monodesmosidic oleanane-type saponins with glucuronic acid linked at 
the C-3 position are very common to this family. More specifically, the sequence 3-O-β-D-
glucuronopyranosyl-22-O-acetyl-3β,22β,24-trihydroxyolean-12-en-30-oic acid is found in 
saponins isolated from Wisteria [56-59, 66], Derris Wall. [75], and Millettia Wight & Arn. 
[67] genera, which belong to the subfamily Faboideae. This may represent a chemotaxonomic 
marker of this subfamily. 
 
Table 6. 
13
C NMR and 
1
H NMR data of the sugar moiety of 
compound 7 in Pyridine-d5(  in ppm) 
Position C H (J in Hz) 
GlcA-1 104.3 4.77 d (7.6) 
2 81.1 4.00 dd (8.4, 7.6) 
3 78.2 4.11 dd (8.4, 8.0) 
4 73.4 3.97 
5 75.0 3.98 
6 174.7 - 
Xyl-1 105.2 5.21 d (6.9) 
2 75.4 3.84 
3 78.0 3.83 
4 70.4 4.02 
5 66.8 3.47 (dd, J = 12.0, 10.0), 
4.22 (dd, J = 12.0, 5.6) 
                                    Overlapped proton signals are reported without designated multiplicity. 
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Table 7. 
13
C NMR and 
1
H NMR data of compound 7 in Pyridine-
d5(  in ppm) 
Position C H (J in Hz) 
Aglycone   
1 38.8 0.91 (m), 1.47 (m) 
2 26.2 1.94 (m), 2.49 (m) 
3 89.9 3.46 
4 44.0 - 
5 56.2 0.88 (br d, J = 10.5) 
6 18.7 1.43(m), 1.66(m) 
7 32.8 1.26(m), 1.45(m) 
8 39.9 - 
9 47.5 1.58 (d, J = 14.0, 6.8) 
10 36.4 - 
11 23.8 1.78 m, 1.82 m 
12 123.3 5.46 (br t, J = 3.0) 
13 144.0 - 
14 41.7 - 
15 26.1 1.78 (m), 1.90 (m) 
16 25.9 0.98 (m), 1.76 (m) 
17 36.0 - 
18 44.0 2.82(dd, J = 12.8, 3.4) 
19 41.5 1.79 (dd), J = 13.5, 3.4), 
2.22(dd, J = 13.5, 12.8) 
20 40.6 - 
21 35.0 1.74(dd, J = 13.6, 3.0), 
2.69 (brd, J = 13.6) 
22 77.8 4.75 (br s) 
23 22.6 1.36 (s) 
24 62.7 3.48(d, J = 11.2), 
4.25 (d, J = 11.2) 
25 15.4 0.82(s) 
26 16.7 0.91(s) 
27 26.2 1.26(s) 
28 21.2 0.93 (s) 
29 29.7 1.27(s) 
30 179.2 - 
Acetyl at C-22   
CO 170.2 - 
CH3 21.1 2.07 (s) 
        Overlapped proton signals are reported without designated multiplicity. 
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Figure 40: Stucture of saponins 7-11 
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Weigela florida “rumba” 
Three new triterpene glycosides 12-14 were isolated from an aqueous-ethanolic extract 
of the roots of Weigela florida “rumba” (Bunge) A. DC., by various solid/liquid 
chromatographic methods. Their structures were determined by 2D NMR and mass 
spectrometry as follow. 
 
The HR-ESIMS (positive-ion mode) spectrum of compound 12 established its 
molecular formula as C61H98O27 with a pseudo-molecular peak at m/z 1285.5334 [M + 
Na]
+
(calcd 1285.6193[M + Na]
+
) indicating a molecular weight of 1262 (Figure 41).  
 
 
Figure 42: Positive ESIMS of saponin 12 
 
The 
1
H NMR spectrum of the aglycone part of 12 displayed signals assignable to 
seven angular methyl groups at H0.76, 0.89, 0.90, 0.93, 1.03, 1.21 and 1.23(s, each), one 
olefinic proton at H5.42(H-12) and one oxygen-bearing methine protons at H 3.23 (H-3).The 
HMBC spectrum showed 
2
J and 
3
J couplings from the methyl protons (23, 24, 25, 26, 27, 29 
and 30), which allowed the assignments of most carbons and protons of this aglycon. The 
deshielded chemical shift of C-28 observed at δC 180.2 suggested the presence of a carbonyl 
group of a carboxylic acid function. According to the literature data, this genin was identified 
as oleanolic acid, already described in saponins from Weigela stelzneri [47] (Table 8). 
 
The HSQC spectrum of 12 displayed signals of six anomers at δH 4.78 (d, J = 7.8 
Hz)/δC 102.4, δH4.80 (d, J = 6.2 Hz) /δC 104.7, δH 4.86 (d, J = 6.9 Hz)/δC 102.1, δH 5.19 (d, J 
= 7.1 Hz)/δC 106.3, δH 5.36 (d, J = 6.9 Hz)/δC 104.6, and δH 6.06 (br s)/δC 101.1 (Figure 42, 
43 and 44). The ring protons of the monosaccharide residues were assigned starting from the 
readily identifiable anomeric protons by means of the 
1
H-
1
H COSY, TOCSY, HSQC and 
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HMBC experiments. The monosaccharides obtained by acid hydrolysis of 12 were identified 
by comparison on TLC with authentic samples as xylose, arabinose and rhamnose. The 
absolute configurations were determined to be D for xylose, and L for arabinose and rhamnose 
by GC analysis according to a method previously described [64]. The relatively large 
3
JH-1,H-2 
value of the Xyl and Ara (6.2-7.8 Hz) in their pyranose form indicated a β anomeric 
orientation for Xyl, and an α anomeric orientation for Ara. The large 1JH-1,C-1 value of the Rha 
(166 Hz) confirmed that the anomeric proton was equatorial (α-pyranoid anomeric form). 
 
Units of one α-L-arabinopyranosyl, one α-L-rhamnopyranosyl and four β-D-
xylopyranosyl were thus identified (Table 9).The monodesmosidic structure was elucidated 
by using mainly HMBC and NOESY spectra: the HMBC correlation at δH 4.80 (Ara-1) / δC 
88.5 (C-3) and the NOESY correlation at δH 4.80 (Ara-1) / δH 3.23 (H-3) confirmed the O-
heterosidic linkage between Ara and C-3 of the aglycon. The HMBC cross-peak at δH 6.06 
(Rha-1)/δC 75.2 (Ara-2) and the NOESY cross-peak at δH 6.06 (Rha-1)/δH4.46 (dd, 6.7, 
6.2)(Ara-2) proved the (12) linkage between Rha and Ara. The correlation at δH 5.19 (Xyl I-
1)/δC 82.0 (Rha-3) in the HMBC spectrum, and at δH 5.19 (Xyl I-1)/δH 4.62 (dd, 9.5, 2.3) 
(Rha-3) in the NOESY spectrum, confirmed the (13) linkage between Xyl I and Rha.The 
HMBC cross-peak at δH 4.78 (Xyl II-1)/δC 76.6 (Xyl I-4) and the NOESY cross-peak at δH 
4.78 (Xyl II-1)/δH 4.10 (Xyl I-4) proved the (14) linkage between Xyl II and Xyl I. Finally, 
the structure analysis of the terminal sequence β-D-xylopyranosyl-(12)-[β-D-xylopyranosyl-
(14)]-β-D-xylopyranosyl was based upon the HMBC correlation at δH 5.36 (Xyl IV-1)/δC 
81.2 (Xyl II-4), the NOESY correlation at δH 5.36 (Xyl IV-1)/δH 4.20 (Xyl II-4) and the 
HMBC cross-peak at δH 3.93 (dd, 8.1, 7.8)(Xyl II-2) / δC 102.1 (Xyl III-1) (Table 9, Figure 
45). 
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Figure 42: General HSQC of saponin 12 
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Figure 43: HSQC anomers zone of saponin 12 
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Figure 44: HSQC spectrum of saponin 12 
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Figure 45: HMBC spectrum of saponin 12 
 
On the basis of the above results, the structure of the previously undescribed 
compound 12 was elucidated as 3-O-β-D-xylopyranosyl-(12)-[β-D-xylopyranosyl-(14)]-
β-D-xylopyranosyl-(14)-β-D-xylopyranosyl-(13)-α-L-rhamnopyranosyl-(12)-α-L-
arabinopyranosyloleanolic acid (12). 
 
The HR-ESIMS (positive-ion mode) spectrum of compound 13 established its 
molecular formula as C62H100O28, as compound 12. Its ESIMS (positive-ion mode) showed a 
pseudo-molecular peak at m/z 1315.5336 [M + Na]
+ 
(calcd 1315.6299[M + Na]
+
) indicating a 
molecular weight of 1292, differing from 12 from 30 uma (Figure 46).  
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Figure 46: Positive ESIMS of saponin 13 
 
The 
1
H and 
13
C NMR signals of compounds 12 and 13 were almost surimposable 
excepted for the terminal hexose linked at the C-4 position of Xyl II. The full NMR 
assignments of this remaining sugarand the GC MS data, led to the identification of a β-D-
glucopyranosylmoiety. The NOESY correlation at δH 5.27 (Glc-1)/δH 4.23 (Xyl II-4) 
established the structure of the previously undescribed compound 13 as 3-O-β-D-
xylopyranosyl-(12)-[β-D-glucopyranosyl-(14)]-β-D-xylopyranosyl-(14)-β-D-
xylopyranosyl-(13)-α-L-rhamnopyranosyl-(12)-α-L-arabinopyranosyloleanolic acid (13) 
(Figure 47, 48, 49 and 50).  
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Figure 47: General HSQC spectra of saponin 13 
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Figure 48: HSQC anomers zone of saponin 13 
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Figure 49: HSQC spectrum of saponin 13 
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Figure 50: HMBC spectrum of saponin 13 
 
 
The HR-ESIMS (positive-ion mode) spectrum of compound 14 established its 
molecular formula as C46H74O15. Its ESIMS (positive-ion mode) showed a pseudo-molecular 
peak at m/z 889.4410 [M + Na]
+
(calcd 889.4925 [M + Na]
+
) indicating a molecular weight of 
866 (Figure 51).  
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Figure 51: Positive ESIMS of saponin 14 
 
The 
1
H NMR spectrum of the aglycone part of 14 displayed signals assignable to 
seven angular methyl groups at H 0.76, 0.88, 0.90, 0.94, 1.03, 1.22 and 1.24 (s, each), one 
olefinic proton at H 5.44(br t, 3.1), and one oxygen-bearing methine protons at H 3.22 (H-3). 
In the 
13C NMR spectrum, a signal at δC 180.2 suggested acarboxylic acid function (C-28). As 
for 12 and 13, the genin of 14 was identified as oleanolic acid [47] (Table 8). 
 
The HSQC spectrum of 14 displayed signals of three anomers at δH 4.79 (d, 6.0)/ δC 
104.7, δH 5.22 (d, 7.6)/δC 106.6, and δH 6.08 (br s)/δC 101.0 (Figure 52, 53 and 54). By 2D 
NMR and GC analysis, units of one α-L-arabinopyranosyl, one α-L-rhamnopyranosyl and one 
β-D-xylopyranosyl were identified (Table 9). The structural analysis of the oligosaccharidic 
chain linked at the C-3 of the aglycon was realizedusing mainly HMBC and NOESY spectra. 
The HMBC correlation at δH 4.79 (Ara-1)/δC 88.5 (C-3) and the NOESY correlation at δH 
4.79 (Ara-1)/δH 3.22 (H-3) confirmed the O-heterosidic linkage between Ara and C-3. The 
HMBC cross-peak at δH 6.08 (Rha-1)/δC 75.1 (Ara-2) and the NOESY cross-peak at δH 6.08 
(Rha-1)/δH 4.47 (d, 6.9, 6.0) (Ara-2) proved the (12) linkage between Rha and Ara. The 
correlation at δH 5.22 (Xyl I-1)/δC 82.0 (Rha-3) in the HMBC spectrum and at δH 5.22 (Xyl I-
1)/δH 4.63(dd, 9.5, 2.9) (Rha-3) in the NOESY spectrum, confirmed the (13) linkage 
between Xyl I and Rha (Table 9, Figures 55 and 56). 
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Figure 52: General HSQC spectrum of saponin 14 
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Figure 53: HSQC anomers zone of saponin 14 
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Figure 54: Sugar moities of saponin 14 
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Figure 55: HMBC spectrum of saponin 14 
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Figure 56: NOESY spectrum of saponin 14 
 
On the basis of the above results, the structure of the previously undescribed 
compound 14 was elucidated as 3-O-β-D-xylopyranosyl-(13)-α-L-rhamnopyranosyl-(12)-
α-L-arabinopyranosyloleanolic acid (14). This sequence was already found in saponins from 
Weigela stelzneri [47]. Other species should be investigated to confirm this sequence as a 
chemotaxonomic marker of the genus Weigela. 
 
From the roots of Weigela florida “rumba”, three new triterpene glycosides were 
identified as 3-O-β-D-xylopyranosyl-(12)-[β-D-xylopyranosyl-(14)]-β-D-xylopyranosyl-
(14)-β-D-xylopyranosyl-(13)-α-L-rhamnopyranosyl-(12)-α-L-
arabinopyranosyloleanolic acid (12),  3-O-β-D-xylopyranosyl-(12)-[β-D-glucopyranosyl-
(14)]-β-D-xylopyranosyl-(14)-β-D-xylopyranosyl-(13)-α-L-rhamnopyranosyl-(12)-α-
L-arabinopyranosyloleanolic acid (13) and 3-O-β-D-xylopyranosyl-(13)-α-L-
rhamnopyranosyl-(12)-α-L-arabinopyranosyloleanolic acid (14) (Figure 57). 
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Table 8. 
13
C NMR and 
1
H NMR data of the aglycones of compounds 12-14 in Pyridine-d5 ( in ppm, J in 
Hz) 
 
No
siti
on 
12 13 14 
 C H  C H  C H 
1 38.6 0.88 (m), 1.43 (m) 38.5 0.84 (m), 1.42 (m) 38.6 0.88 (m), 1.42 (m) 
2 26.3 1.78 (m), 2.02 (m) 26.2 1.74 (m), 2.00 (m) 23.3 1.88 (m), 2.04 
3 88.5 3.23  88.5 3.22 88.5 3.22 
4 39.2 - 39.2 - 39.4 - 
5 55.7 0.73 (br d, 12.2) 55.6 0.71 (br d, 11.6) 55.7 0.72 (br d, 12.2) 
6 18.2,  1.23, 1.47 (m) 18.2 1.20, 1.45 (m) 18.1 1.45, nd 
7 32.8, 1.22, 1.43 (m) 32.9 1.19, 1.40 (m) 32.8 1.17, 1.38 (m) 
8 39.4 - 39.3 - 39.2 - 
9 47.7 1.57 (dd, 14.1, 8.1) 47.7 1.55 (dd, 15.0, 9.0) 47.7 1.57 (dd, 14.0, 8.6) 
10 36.6 - 36.7 - 36.7 - 
11 23.5 1.83 (m), 1.91 23.4 1.82 (m), 1.86 23.5 1.82 (m), 1.86 
12 122.2 5.42  122.2 5.40 (br t, 3.0) 122.2 5.44 (br t, 3.1) 
13 144.5 - 144.4 - 144.5 - 
14 41.8 - 41.8 - 41.8 - 
15 28.0 1.14 (m), 2.08 (m) 27.8 1.13 (m), 2.03 (m) 28.0 1.12 (m), 2.06 (m) 
16 23.3 1.91, 2.06(m) 23.3 1.89 (m), 2.05 (m) 26.3 1.75 (m), 2.01 (m) 
17 46.4 - 46.4 - 46.4 - 
18 41.7 3.23  41.6 3.20  41.6 3.20  
19 46.2 1.22, 1.73  46.1 1.20, 1.72  46.2 1.19, 1.74  
20 30.6 - 30.6 - 30.6 - 
21 33.9 1.11 (m), 1.35 (m) nd nd 33.9 1.12 (m), 1.37 (m) 
22 32.8 1.70, 1.89  32.8 1.73, nd 32.8 1.71 1.78  
23 27.9 1.21 (s) 27.8 1.19 (s) 27.9 1.22 (s) 
24 16.8 1.03 (s) 16.7 1.01 (s) 16.8 1.03 (s) 
25 15.2 0.76 (s) 15.2 0.75 (s) 15.2 0.76 (s) 
26 17.1 0.90 (s) 17.0 0.89 (s) 17.1 0.90 (s) 
27 25.9 1.23 (s) 25.8 1.22 (s) 25.9 1.24 (s) 
28 180.2 - 180.3 - 180.2 - 
29 33.0 0.89 (s) 33.8 0.88 (s) 33.0 0.88 (s) 
30 23.5 0.93 (s) 23.4 0.92 (s) 23.5 0.94 (s) 
Overlapped proton signals are reported without designated multiplicity. 
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Table 9.  
13
C NMR and 
1
H NMR data of the sugar moieties of compounds 12-14 in Pyridine-d5  (in ppm, J in 
Hz) 
 
No 
12 13 14 
 C H  C H  C H 
Ara-1 104.7 4.80 (d, 6.2) 104.6 4.79 (d, 6.2) 104.7 4.79 (d, 6.0) 
2 75.2 4.46 (dd, 6.7, 6.2) 75.1 4.45 (dd, 6.9, 6.2) 75.1 4.47 (dd, 6.9, 6.0) 
3 73.7 4.21 73.5 4.20 73.7 4.19 
4 68.6 4.24 (m) 68.5 4.24 (m) 68.6 4.23 (m) 
5 64.8 3.77 (br d, 10.7), 4.26 64.7 3.76 (br d, 9.8), 4.27 64.9 3.75 (br d, 10.7), 4.25 
Rha-1 101.1 6.06 (br s) 101.0 6.03 (br s) 101.0 6.08 (br s) 
2 71.4 4.80 (br s) 71.3 4.79 (br s) 71.4 4.80 (br s) 
3 82.0 4.62 (dd, 9.5, 2.3) 82.0 4.59 (dd, 9.3, 2.7) 82.0 4.63 (dd, 9.5, 2.9) 
4 72.2 4.39 (dd, 9.5, 9.3) 72.2 4.37 72.3 4.39 (t, 9.5) 
5 69.4 4.53 (dq, 9.3, 6.0) 69.4 4.51 (dq, 9.5, 6.0) 69.4 4.53 (dq, 9.5, 6.2) 
6 18.1 1.49 (d, 6.0) 18.0 1.49 (d ,6.0) 18.1 1.48 (d, 6.2) 
Xyl I-1 106.3 5.19 (d, 7.1) 106.1 5.16 (d, 7.4) 106.6 5.22 (d, 7.6) 
2 74.3 4.01 (dd, 7.8, 7.1) 74.7 3.99 75.0 4.01 (dd, 8.6, 7.6) 
3 75.3 4.07 75.2 4.05 77.6 4.08 (dd, 8.6, 8.3) 
4 76.6 4.10 76.6 4.07 70.5 4.10 (m) 
5 64.4 3.52 (t, 10.7), 4.28 64.1 3.50 (t, 10.0), 4.28 66.8 3.58 (t, 10.5), 4.20 
Xyl II-1 102.4 4.78 (d, 7.8) 102.3 4.76 (d, 7.4)   
2 73.3 3.93 (dd, 8.1, 7.8) 73.1 3.92 (dd, 8.6, 7.4)   
3 71.7 4.12 72.2 4.14   
4 81.2 4.20 82.0 4.23   
5 64.2 3.58, 4.34 64.1 3.56, 4.34   
Xyl III-1 102.1 4.86 (d, 6.9) 101.8 4.87 (d, 6.7)   
2 72.2 3.96 (dd, 7.4, 6.9) 72.2 3.98   
3 76.1 4.09 75.7 4.06   
4 70.1 4.07 69.9 4.07   
5 66.1 3.60, 4.30 65.9 3.58, 4.30   
Xyl IV-1 104.6 5.36 (d, 6.9)    
2 74.3 4.02    
3 76.6 4.08    
4 70.1 4.07    
5 66.1 3.60, 4.34    
Glc I-1   104.5 5.27 (d, 7.9)   
2   74.7 3.98   
3   77.6 4.11   
4   70.8 4.01   
5   78.1 3.84 (m)   
6   62.0 4.14, 4.37   
Overlapped proton signals are reported without designated multiplicity.  
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Figure 57: Structure of saponins 12-14 
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Polygala acicularis 
Two triterpene glycosides were isolated from the roots of Polygala acicularis. They 
were identified mainly by 2D NMR spectroscopic analysis (COSY, TOCSY, NOESY, HSQC, 
HMBC) and mass spectrometry, as 3-O-ß-D-glucopyranosyl-presenegenin-28-O-ß-D-
xylopyranosyl-(14)--L-rhamnopyranosyl-(12)-(3,4-di-O-acetyl)-ß-D-fucopyranosyl ester 
(15), and 3-O-ß-D-glucopyranosyl-presenegenin-28-O-ß-D-xylopyranosyl-(14)--L-
rhamnopyranosyl-(12)-[4-O-(E)-3,4-dimethoxycinnamoyl]-ß-D-fucopyranosyl ester (15). 
 
Compound 15, a white amorphous powder, showed in HR ESIMS (positive-ion mode) 
a quasimolecular ion peak [M + Na]
+
 at m/z 1373.5808 indicating a molecular weight of 1350, 
compatible with a molecular formula of C63H98O31 (Figure 58).  
 
 
Figure 58:  Positive ESIMS of saponin 15 
 
The spectroscopic NMR data of the prosapogenin of 15 were in good agreement with 
those of tenuifolin (3-O-ß-D-glucopyranosyl-presenegenin), commonly encountered in the 
Polygalaceae family [42-43]. The 
1
H NMR spectrum of 15 displayed signals for five 
anomeric protons at H 6.40 (br s), 6.06 (d, J = 8.1 Hz), 5.04 (d, J = 7.0 Hz), 4.93 (d, J = 7.6 
Hz), 4.84 (d, J = 7.0 Hz), which gave correlations, in the HSQC spectrum, with carbon signals 
at C 102.0, 94.2, 104.5, 103.9, and 106.9 respectively (Figures 59 and 60). The ring protons 
of the monosaccharide residues were assigned starting from the readily identifiable anomeric 
protons by means of the COSY, TOCSY, HSQC, HMBC experiments (Tables 10 and 11) 
Evaluation of spin-spin couplings and chemical shifts allowed the identification of one ß-
fucopyranose (Fuc), one -rhamnopyranose (Rha), one ß-glucopyranose (Glc), one ß-
xylopyranoses (Xyl), and one ß-galactopyranose (Gal) units. The common D-configuration for 
Fuc, Glc, Xyl, and Gal, and the L-configuration for Rha were assumed by GC MS as 
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previously described. Correlations observed in the HMBC spectrum between signals at H 
5.04 (Glc-1) and C 86.9 (C-3), and in the ROESY spectrum between H 5.04 (Glc-1) and H 
4.62 (H-3), confirmed the substitution at the C-3 position of the presenegenin by a 3-O-ß-D-
glucopyranose. After subtraction of the anomeric signals of the glucosyl moiety, the signals of 
four sugars linked to the aglycon by an ester linkage remained. In the HMBC spectrum, a 
correlation between signals at H 6.06 (d, J = 8.1 Hz, Fuc-1) and C 176.5 (C-28) proved a 
glycosidic ester linkage to the C-28 of the aglycon. A ROESY correlation between signals at 
H 6.40 (Rha-1) and H 4.71 (dd, J = 8.8, 8.1 Hz) (Fuc-2) revealed the (12) linkage between 
these two sugars. The signals at H (Fuc-3) and H (Fuc-4) were shifted downfield at H 5.54 
and H 5.52 respectively and the presence of two acetyl methyl signals at H 2.06 (s) and H 
2.10 (s) suggested the Fuc-3 and Fuc-4 substitution by two acetyl groups. According to the 
HMBC correlation between H 4.21 (Rha-4) and C 106.9 (Xyl-1), and a reverse one between 
H 4.84 (Xyl-1) and C 86.2 (Rha-4), we concluded that saponin 15 presented the sequence 3-
O-ß-D-glucopyranosyl-presenegenin-28-O-ß-D-xylopyranosyl-(14)--L-rhamnopyranosyl-
(12)-(3,4-di-O-acetyl)-ß-D-fucopyranosyl ester (Figure 61), which has been already 
encountered in four Polygalaceae, Polygala fallax [76], Polygala renii [77], Carpolobia alba 
[78] and Carpolobia lutea [78]. Moreover, the assignments of the 
1
H and 
13
C NMR signals of 
a terminal ß-D-galactopyranose were deduced from the TOCSY, HSQC, HMBC and ROESY 
spectra. A HMBC cross-peak at H 4.93 (Gal-1) / C 77.2 (Xyl-4), and a ROESY cross-peak at 
H 4.93 (Gal-1) / H 4.36 (Xyl-4), suggested a substitution of the position 4 of the xylose by 
this terminal galactose. 
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Figure 59: General HSQC of saponin 15 
 
Figure 60: HSQC spectrum of saponin 15 
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Figure 61: ROESY spectrum of saponin 15 
 
The structure of 15 was thus established as 3-O-ß-D-glucopyranosyl-presenegenin-28-
O-ß-D-galactopyranosyl-(13)-ß-D-xylopyranosyl-(14)--L-rhamnopyranosyl-(12)-(3,4-
di-O-acetyl)-ß-D-fucopyranosyl ester (15) (Figure 62). This molecule was already isolated 
from another species of Polygala, P. fallax, and named Polygalasaponin XXXV [76]. 
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The 
1
H- and 
13
C-NMR signals of 16 assigned from the 2D spectra, were almost 
superimposable on those of 15 excepted for the ß-D-fucopyranosyl moiety (Tables 10 and 11). 
The downfield shifts observed in the HSQC spectrum for the H-C(4)/(C4) resonances of the 
Fuc at H 5.68/C 74.7 proved the secondary alcoholic function at the 4 position of the Fuc to 
be acylated. The Fuc-4 position was substituted by a (E)-3,4-dimethoxycinnamoyl. This acyl 
moiety appeared as two doublets at H 6.53 and 7.88 (1H each, J = 16 Hz). The full 
assignments of the carbons and protons of the 3,4-dimethoxycinnamoyl unit obtained by 
further 2D-NMR investigations, were in good agreement with those described in literature 
[79] (Table 10). 
 
This molecule was identified as 3-O-ß-D-glucopyranosyl-presenegenin-28-O-ß-D-
galactopyranosyl-(13)-ß-D-xylopyranosyl-(14)--L-rhamnopyranosyl-(12)-[4-O-(E)-
3,4-dimethoxycinnamoyl]-ß-D-fucopyranosyl ester (16) (Figure 62), previously isolated from 
Polygala senega [79], and named senegin II. 
 
In conclusion, we found in this plant two saponins possessing a common sequence 3-
O-ß-D-glucopyranosylpresenegenin 28-O-ß-D-galactopyranosyl-(14)-ß-D-xylopyranosyl-
(14)--L-rhamnopyranosyl-(12)-ß-D-fucopyranosyl ester, with additional acylations of 
the Fuc-4 and/or Fuc-3 positions. A chemotaxonomic marker has already been identified in 
the Polygalaceae which is 3-O-ß-D-glucopyranosylpresenegenin 28-O-ß-D-xylopyranosyl-
(14)--L-rhamnopyranosyl-(12)-ß-D-fucopyranosyl ester [42-43]. These results 
corroborated those previously described for saponins isolated from this family.  
The structural analysis of three other isolated molecules, identified as sucrose esters, is 
in progress.  
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Table 10. 
13
C NMR and 
1
H NMR data of the aglycones of compounds 
15 and 16 in Pyridine-d5/D2O ( ppm, J in Hz) 
 
 15 16 
Position C H  C H  
1 44.0 1.37, 2.23  44.2 1.33, 2.19  
2 71.0 4.64  71.0 4.58  
3 89.9 4.62  87.0 4.56  
4 53.3 - 53.1 - 
5 52.2 2.22 52.4 2.19 
6 21.2 1.80, 1.86  20.1 1.90, 2.08  
7 33.7 1.02, 1.21 33.9 1.00, 1.19 
8 40.9 - 41.2 - 
9 49.1 2.27 49.3 2.23 
10 36.6 - 36.8 - 
11 23.4 nd 23.4 nd 
12 127.4 5.80 (br t, 3.0) 127.3 5.73 (br t, 3.0) 
13 139.2 - 139.5 - 
14 47.8 - 48.0 - 
15 24.0 1.70, 2.06 23.0 1.90, 2.10 
16 23.5 nd 23.5 nd 
17 47.0 - 46.9 - 
18 41.6 3.15 (dd, 13.6, 3.1) 41.8 3.11 (dd, 13.5, 3.0) 
19 45.2 1.26, 1.69 45.2 1.22, 1.65 
20 30.5 - 30.6 - 
21 33.5 1.84, 2.25 33.9 2.17, nd 
22 32.1 1.73, 1.88 nd nd 
23 184.8  185.0  
24 14.8 1.87 (s) 14.6 1.82 (s) 
25 17.2 1.43 (s) 17.4 1.39 (s) 
26 18.4 1.03 (s) 19.0 0.96 (s) 
27 64.1 3.84, 4.10 
 
64.1 3.77, 4.08 
 28 176.5  176.5  
29 32.8 0.78 (s) 33.1 0.75 (s) 
30 23.5 0.81 (s) 23.4 0.77 (s) 
  Nd : Not determined 
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Table 11. 
13
C NMR and 
1
H NMR data of the sugar moieties and the 3,4-
dimethoxycinnamoyl group of compounds 15 and 16 in Pyridine-d5/D2O ( 
ppm, J in Hz) 
 
 15 16 
Position C H   C H  
Glc-1 104.5 5.04 (d, J = 7.0) 104.3 4.99 (d, J = 7.2) 
2 76.0 3.93  74.8 3.87  
3 77.3 4.24  76.9 4.19 
4 71.1 4.04  70.9 3.98 
5 77.7 3.91 m 77.1 3.86 m 
6 62.2 4.16, 4.36 61.9 4.12, 4.34 
Fuc-1 94.2 6.06 (d, J = 8.1) 93.9 6.02 (d, J = 8.1) 
2 74.5 4.71 (dd, J = 8.8, 8.1) 74.0 4.66 (dd, J = 8.8, 8.1) 
3 76.3 5.54 74.1 4.42 
4 72.3 5.52 74.7 5.68 
5 70.3 4.17 70.5 4.11 
6 15.9 1.14 (d, J = 6.4) 16.3 1.26 (d, J = 6.2) 
Ac at Fuc-3 171.1    
 20.3 2.06 (s)   
Ac at Fuc-4 170.4    
 20.5 2.10 (s)   
Rha-1 102.0 6.40 (br s) 101.4 6.35 (br s) 
2 71.2 4.79 (br s) 71.2 4.73 (br s) 
3 72.3 4.58 72.3 4.58 
4 86.2 4.21 85.1 4.15 
5 68.0 4.47 67.8 4.30 
6 18.4 1.73 (d, J = 5.9) 18.4 1.65 (d, J = 5.7) 
Xyl-1 106.9 4.84 (d, J = 7.0) 106.7 4.80 (d, J = 7.0) 
2 75.5 4.04 75.3 3.97 
3 76.9 4.09 76.4 4.02 
4 77.2 4.36 76.7 4.30 
5 64.7 3.42 (t, J = 8.2), 4.34 64.5 3.37 (t, J = 8.8), 4.30 
Gal-1 103.9 4.93 (d, J = 7.6) 103.7 4.89 (d, J = 7.1) 
2 71.2 4.44 70.9 4.40 
3 75.0 4.10 74.4 4.05 
4 69.9 4.32 69.8 4.27 
5 76.0 4.01 m 76.4 4.02 
6 62.2 4.18, 4.42 61.9 4.12, 4.36 
3,4-dimethoxycinnamoyl   
C()   167.6  
CH()   115.6 6.53 (d, J=16.0) 
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CH()   146.0 7.88 (d, J=16.0) 
C(1)   127.3  
CH(2)   110.6 7.04 (s) 
C(3)   149.0  
C(4)   151.8  
CH(5)   111.7 6.93 (d, J=8.3) 
CH(6)   123.1 7.03 (d, J=8.3) 
MeO-C(3)   55.6 3.76 (s) 
MeO-C(4) 
 
  55.6 3.78 (s) 
           Nd : Not determined 
 
 
 
Figure 62: Structure of saponins 15 and 16 
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Chapter 3: Peptide and glycopeptide synthesis and immunoenzymatic 
assays 
3.1 Material and methods 
3.1.1 Peptide and glycopeptide synthesis 
 
The N-glucosylated peptide CSF114(Glc) and its unglucosylated analog were prepared 
by a microwave-assisted solid-phase peptide synthesis. Peptides were purified by solid-phase 
extraction and high pressure liquid chromatography (HPLC) and further characterized by 
mass spectrometry and analytical HPLC.  
3.1.2 Ursolic acid 
 
Ursolic acid ≥90%, a triterpenic acid was purchased to Sigma Aldrich (Figure 63). 
 
Figure 63: Structure of ursolic acid (17) 
3.1.3 Prosapogenin tenuifolin obtained by mild alkaline hydrolysis 
 
A crude saponin extract from Polygala acicularis (15mg) was refluxed with 5% 
aqueous KOH solution (50ml) for 2h. The mixture was adjusted to pH 7 with diluated HCl 
solution and then extracted with H2O-saturated BuOH (3x50ml). The combined BuOH 
extracts were washed with H2O and concentrated to dryness to obtain the prosapogenin named 
tenuifolin (Figure 64). 
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Figure 64:  Structure of prosapogenin tenuifolin (18) 
3.1.4 Extraction of rutoside from Sophora japonica 
 
Sophora japonica L. is a majestic Chinese tree from the Fabaceae family (Figure 65). 
It can measure until 25 meter and it is used as ornamental tree in European gardens. In the 
past, Chinese people used flower buds to dye the silk in yellow and now flower buds are 
extracted because they countain around 15-20% of a flavonoid glycoside, named rutoside or 
rutin. This flavonoid is a quercetin diglycoside, which possess interesting pharmacological 
properties (Figure 66) [80-82].  
 
 
Figure 65: Sophora japonica 
http://mon-herbier.teznet.fr/planches/DP0208 
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The protocol used to obtain rutoside from the flower buds of Sophora japonica was 
described in the literature [80]. 10 g of dried flower buds were crushed and mixed with 100 
ml of methanol. The mixture was either refluxed during 1h, then it was filtered and the 
solvent removed. The dry residue was dissolved in water to convert it into the hydrated form, 
which precipitates from solution. The mixture was extracted with diethylether to remove 
chlorophyl and the precipitate in the aqueous phase was collected by vaccum filtration and 
dried in an oven at 70°C. 
 
Figure 66: Structure of rutoside (19) 
3.1.5 Peptide synthesis 
 
Sequence CSF114:   
Thr-Pro-Arg-Val-Glu-Arg-Asn-Gly-His-Ser-Val-Phe-Tyr-Gly-Trp-Met-Val-Lys 
 
The resin is swollen for 30 min with DMF (2 mL/100 mg of resin) before use. Each 
amino-acid cycle is characterized by the following four steps: 
First Fmoc-deprotection: Resin is stirred (1 × 5 min) with a solution of 20% piperidine 
in DMF (1 mL/100 mg of resin). Washing: DMF (2 × 3 min). 
Second Fmoc-deprotection: Resin is stirred (1 × 15 min) with a solution of 20% 
piperidine in DMF (1 mL/100 mg of resin). Washing: DMF (2 × 3 min), DCM (2 x 3min), 
DMF (1 x 3min). 
Coupling reaction: Fmoc-protected amino acids (5 eq), TBTU (5 eq) and DIPEA 
(74µL) were dissolved in DMF with a final dilution of 1 mL DMF for 100 mg of resin. 
Couplings were performed for 30 min at room temperature. Washing: DMF (2 × 3 min) and 
DCM (2 × 3 min). After DCM washing each coupling reaction is monitored by Kaiser test. 
After the last Fmoc-removal the resin is washed with DCM and dried under vacuum. 
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Kaiser test: 
To a small amount of peptide-resin placed in a test tube, three drops for each of the 
following solutions were added: ninhydrine (5 g) in ethanol (100 mL); phenol (80 g) in 
ethanol (20 mL); KCN (2 mL of 1 mM aqueous solution) in pyridine (98 mL). The tube is 
heated at 100 °C for 5 min. A positive test (resin beads and solution appears strongly blue-
violet) states the presence of at least 5% free amino groups. 
 
Cleavage: 
Cleavages from the resin and side chain deprotection were performed using a cleavage 
mixture depending on the sequence and modified amino acids introduced, as indicated for 
each compound. The peptide-resin is treated for 3 h with cleavage mixture (1 mL × 100 mg of 
resin) at room temperature. The resin is filtered off and the solution is concentrated flushing 
with N2. The peptide is precipitated from cold diethylether, centrifuged and lyophilized. 
 
Purification: 
Peptides are purified by Spot Liquid Chromatography Flash (SLCF) to remove salts 
and impurities. It is performed on RP-C18 LiChroprep columns on an automatic Armen 
Instrument. Fractions are checked by analytical RP-HPLC ESI-MS or RP-UPLC ESI-MS, 
product-containing homogeneous ones are pooled together. All peptides are further purified 
by semi-preparative RP-HPLC. All the peptides were obtained with a purity ≥ 95% to be used 
for autoantibody detection. 
 
Sequence CSF114(Glc) :  
Thr-Pro-Arg-Val-Glu-Arg-Asn(Glc)-Gly-His-Ser-Val-Phe-Tyr-Gly-Trp-Met-Val-Lys 
 
 The protocol is the same as the unglucosylated sequence except for the addition of 
asparagine glucosylated. The modified amino acid Fmoc-Asn[Glc(OAc)4] is manually 
introduced. Couplings are performed with an excess of 2.5 eq of modified amino acid, 2.5 eq 
of HATU as activator, and 3.5 eq of DIPEA, for 1 hour at room temperature. Deprotection of 
the hydroxyl functions of sugar moieties linked to the N-glycosylated peptides was performed 
in basic conditions (pH 11-12) using a fresh sodium methanolate solution. 
 Purification was performed by Spot Liquid Chromatography Flash (SLCF) to 
remove salts and impurities. It is performed on RP-C18 LiChroprep columns on an automatic 
Armen Instrument. Fractions are checked by analytical RP-HPLC ESI-MS or RP-UPLC ESI-
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MS, product-containing homogeneous ones are pooled together. Peptide is further purified by 
semi-preparative RP-HPLC. CFS114(Glc) with a purity ≥ 95% was used for autoantibody 
detection. 
3.1.6 Immunoenzymatic assays with CSF114(Glc) and its unglucosylated analog 
 
The peptide was coated on 96-well activated polystyrene ELISA plates (NUNC 
Maxisorb) using a solution 10 μl/ml in pure carbonate buffer 0.05 M at pH 9.6 (100 μl/well) 
and incubated at +4°C overnight. After three washes with 150 mM NaCl solution containing 
0.05% Tween 20 (washing buffer), non-specific binding sites were blocked with 10% fetal 
bovine serum (FBS) in washing buffer (100 μl/well) at room temperature for 60 min. Sera 
diluted 1:100 in 10% FBS in washing buffer were incubated at +4°C overnight. After three 
washes, 100 μl of alkaline phosphatase conjugated with anti-human IgM (diluted 1:1200 in 
10% FBS in washing buffer) were added to each well. After 3h incubation at room 
temperature and three washes, 100 μl/well of 1 mg.ml-1 p-nitrophenylphosphate (Sigma-
Aldrich) in carbonate buffer (pH 9.6) was added. After 30min, the reaction was stopped with 
1 M NaOH (50 μl/well), and the absorbance was read in a multichannel ELISA reader (Tecan 
Sunrise, Männedorf, Switzerland) at 405 nm. ELISA plates, coating conditions, reagent 
dilutions, buffers, and incubation times were preliminary tested. Antibody levels are 
expressed as absorbance in arbitrary units at 405 nm (sample dilution 1:100). 
3.1.7 Immunoenzymatic assays of saponins, rutoside and ursolic acid 
 
Saponins, rutoside and ursolic acid were coated on 96-well microplates BD Falcon
TM
 
separately using a solulion 10 μg/ml in pure ethanol (100 μl/well). The plates were then 
incubated at +4°C overnight. The non-specific binding sites were blocked with 10% fetal 
bovine serum (FBS) in 150 mM NaCl solution without surfactant at room temperature for 60 
min. Sera diluted 1:100 in 10% FBS in 150 mM NaCl were incubated at +4°C overnight (100 
μL/well). After three washes, 100 μl of alkaline phosphatase conjugated anti-human IgM 
(Invitrogen) (diluted 1:1500 in 10% FBS washing buffer) were added to each well. After 3h 
incubation at room temperature and three washes, 100 μl/well of 1 mg.ml-1 p-nitrophenyl 
phosphate (Sigma-Aldrich) in carbonate buffer (pH 9.6) with 10 mM MgCl2 solution was 
added. After 30min, the reaction was stopped with 1M NaOH (50μl/well), and the absorbance 
was read in a multichannel ELISA reader (Tecan Sunrise, Männedorf, Switzerland) at 405 
nm. ELISA plates, coating conditions, reagent dilutions, buffers, and incubation times were 
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preliminary tested. Antibody levels are expressed as absorbance in arbitrary units at 405 nm 
(sample dilution 1:100). 
3.1.8 Statistical analysis 
 
Statistical analysis was performed using GraphPad prism 6. Mann-Whitney tests were 
used to evaluate the predictive antibody values; two-tailed p-values andreceiver operating 
characteristic (ROC) curves were calculated. Cut-off values were established. 
3.2 Personal works 
 3.2.1 Selection of molecules 
 
The aim of this PhD thesis was the selection of natural glycosides with different 
structures, bearing different glycosyl moieties and aglycones. Their immunochemical 
characterization in MS and RTT patient sera was thus performed. 
 
For our study, eight glycosides (4, 8, 13, 14, 16, 17, 18 and 19) were chosen to 
perform immunoenzymatic assays in order to measure IgM level in MS patients’ and RTT 
patients’ sera to try to establish structure / activity relationships. Compounds were selected 
according to their structure, seven from natural source (4, 8, 13, 14, 16, 18 and 19) and one 
commercial, ursolic acid (17). The obtained results with these molecules were compared to 
the synthetic peptide CSF114 (Glc), which has already shown its efficiency in the recognition 
of IgM in patients affected by Multiple Sclerosis and Rett syndrome. 
 - Compounds 4 and 8 (Figure 67), monodesmosidic glycosides, possess the same 
oligosaccharidic chains at the C-3 position, as 3-O--L-rhamnopyranosyl-(12)--D-
xylopyranosyl-(12)--D-glucuronopyranosyl. But their aglycons are different: compound 8 
has a primary alcoholic function at C-23, one acetyl group at C-22, and one carboxylic group 
at C-30, while 4 has two primary alcoholic functions at C-23 and C-30, and a rare ketone 
group at C-22. 
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Figure 67: Structure of saponins 4 and 8 
- Compounds 13 and 14 (Figure 68), monodesmosidic, have the same aglycone, 
oleanolic acid, but they differ by the structure, and so by the length, of the oligosaccharidic 
chain at C-3: 3-O-β-D-xylopyranosyl-(13)-α-L-rhamnopyranosyl-(12)-α-L-
arabinopyranosyl for 14, and 3-O-β-D-xylopyranosyl-(12)-[β-D-glucopyranosyl-(14)]-β-
D-xylopyranosyl-(14)-β-D-xylopyranosyl-(13)-α-L-rhamnopyranosyl-(12)-α-L-
arabinopyranosyloleanolic acid for 13. 
 
Figure 68: Structure of saponins 13 and 14 
 
- Compound 16 is a bidesmosidic saponin (Figure 69), with a O-heterosidic linkage at 
C-3 with a 3-O-ß-D-glucopyranosyl moiety and a ester linkage at C-28 with the 
oligosaccharidic chain ß-D-galactopyranosyl-(13)-ß-D-xylopyranosyl-(14)--L-
rhamnopyranosyl-(12)-[4-O-(E)-3,4-dimethoxycinnamoyl]-ß-D-fucopyranosyl. The 
acylation with a 3,4-dimethoxycinnamoyl moiety is often encountered in the Polygalaceae 
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family. The aglycone, the presenegenin, possesses many free oxygenated groups which is not 
so usual: two secondary alcoholic functions at C-2 and C-3 positions, one primary alcoholic 
function at C-27, and two carboxylic functions at C-23 and C-28. 
 
Figure 69: Structure of saponin 16 
 
- Compound 18 (figure 70), a monodesmosidic saponin, was chosen because of the 
only one β-D-glucopyranosyl moiety linked at C-3 position (tenuifolin).  
 
Figure 70: Structure of saponin 18 
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 - An aglycon was chosen, a commercial triterpenic acid, ursolic acid (17), as a 
negative control for the immunoenzymatic assays because of the lack of osidic part in the 
molecule (Figure 71). 
 
Figure 71: Structure of the ursolic acid (17) 
 
 - Finally, a flavonoid glycoside, rutoside (18) was tested to see if the triterpenic nature 
of the aglycon could play a key role in the assays (Figure 72). 
 
Figure 72: Structure of the rutoside (19) 
 
All these eight compounds were tested as mimetics of native antigens to detect an 
immune response performing ELISA tests to measure IgM levels in MS patient and  RTT 
patient sera and normal blood donors. The synthetic N-glucosylated peptide, CSF114(Glc) 
was used as positive control for the recognition of IgMs in Multiple Sclerosis and Rett 
syndrome. 
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 3.2.2 Immunoenzymatic assays on multiple sclerosis patient sera  
3.2.2.1 Selection of Multiple Sclerosis sera 
 
Sera from 19 Multiple Sclerosis patients collected at diagnosis and 11 healthy blood 
donors were obtained for diagnostic purposes and stored at −20°C until use. Multiple 
Sclerosis (MS) patient sera samples were collected in two Multiple Sclerosis Centers: The 
Multiple Sclerosis Clinical Care and Research Centre, Department of Neurosciences, 
Reproductive Sciences and Odontostomatology, Federico II University (Naples, Italy) and the 
Azienda Ospedaliera Universitaria Careggi, Clinica Neurologica, University of Florence 
(Florence, Italy). All patients and healthy donors gave their informed consent. Multiple 
Sclerosis patients were previously diagnosed after a lumbar puncture, MRI examination, and 
cerebrospinal analysis. Samples were pre-selected depending on their reactivity to 
CSF114(Glc). Antibody responses were determined in SP-ELISA. 
3.2.2.2 SP-ELISA results 
 
Below are shown the results of ELISA. Experiments were carried out as described in 
the Experimental part. The sera were used in triplicate with a dilution of 1:100. Data 
distribution ofIgM antibodies responses to compounds 4, 8, 13, 14, 16, 17, 18 and 19 in the 
sera of MS patients and normal blood donors (NBDs) determined by ELISA will be 
presented: 
 
Saponins 4 and 8 which are monodesmosidic ones with the same oligosaccharidic 
chain and a different aglycone demonstrate a difference in the recognition of IgM in MS 
patients. Indeed, Mann-Whitney tests were used to evaluate the predictive IgM antibody 
values and p values of 0.0202 and 0.0052 were found respectively. In this case, the results 
(Figure 73) are not relevant but the different functions on the aglycone could also be 
responsible of IgM recognition. 
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Figure 73: Data distribution of IgM antibody response to saponins 4 and 8 in MS sera and NBDs determined by 
ELISA. Data are reported as absorbance at 405nm of sera diluted 1:100.Statistical analysis was performed using 
Graph prism 6 software. Mann-Whitney tests were used to evaluate the predictive antibody values and two-tailed 
p values were calculated (P value < 0.001=****, P value > 0.001=**, P value >0.01=*) 
 
 Concerning saponins 13 and 14 which are monodesmosidic saponins with the same 
aglycone and an oligosaccharidic chain of different length, no significant results were 
obtained (Figure 74). It appears that these saponins are not able to recognize IgMs in MS sera.  
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Figure 74: Data distribution of IgM antibody responses to saponin 13 and 14 in MS sera and NBDs determined 
by ELISA. Data are reported as absorbance at 405nm of sera diluted 1:100. Statistical analysis was performed 
using Graph prism 6 software. Mann-Whitney tests were used to evaluate the predictive antibody values and 
two-tailed p values were calculated (P value < 0.001=****, P value > 0.001=**, P value >0.01=*) 
 
 The bidesmosidic saponin 16 shows a small difference in detecting Abs in MS sera 
compared toNBDs with a p value of 0.0138 (Figure 75). It appears that this glycoside is not 
able to recognize IgM in MS sera; the results are not significant and are in agreement with 
previous data obtained by Peroni et al, 2016 [33] where similar compounds were tested as 
putative antigens for MS. 
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Figure 75: Data distribution of IgM antibody responses to saponin 16 in MS sera and NBDs determined by 
ELISA. Data are reported as absorbance at 405nm of sera diluted 1:100. Statistical analysis was performed using 
Graph prism 6 software. Mann-Whitney tests were used to evaluate the predictive antibody values and two-tailed 
p values were calculated (P value < 0.001=****, P value > 0.001=**, P value >0.01=*) 
 The triterpenic acid 17 which has no sugars was tested for the recognition of IgMs in 
MS sera. No relevant results were obtained (Figure 76). These data are in agreement with the 
relevant role of the glycosyl moiety for IgM recognition [33]. 
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Figure 76: Data distribution of IgM antibody responses to ursolic acid 17 in MS sera and NBDs determined by 
ELISA. Data are reported as absorbance at 405nm of sera diluted 1:100. Statistical analysis was performed using 
Graph prism 6 software. Mann-Whitney tests were used to evaluate the predictive antibody values and two-tailed 
p values were calculated (P value < 0.001=****, P value > 0.001=**, P value >0.01=*) 
 Saponin 18 which has only one glucose moiety linked in C-3 position and different 
functions on the aglycone demonstrated a p value of 0.0061 (Figure 77). This compound is 
able to recognize IgMs in MS sera but the results are not statistically relevant according to the 
p value. 
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Figure 77: Data distribution of IgM antibody responses to saponin 18 in MS sera and NBDs determined by 
ELISA. Data are reported as absorbance at 405nm of sera diluted 1:100. Statistical analysis was performed using 
Graph prism 6 software. Mann-Whitney tests were used to evaluate the predictive antibody values and two-tailed 
p values were calculated (P value < 0.001=****, P value > 0.001=**, P value >0.01=*) 
 The only flavonoid glycoside 19 available was also tested. According to its structure, 
no significant results were obtained (Figure 78). In this case, we can hypothesize that the 
flavonoid-type aglycone may not allow the sugars to be exposed for the recognition. 
 
n s
1 9
A
b
s
o
r
b
a
n
c
e
 (
4
0
5
n
m
)
M
S
N
B
D
s
0 .0
0 .5
1 .0
1 .5
 
Figure 78: Data distribution of IgM antibody responses to rutoside 19 in MS sera and NBDs determined by 
ELISA. Data are reported as absorbance at 405nm of sera diluted 1:100. Statistical analysis was performed using 
Graph prism 6 software. Mann-Whitney tests were used to evaluate the predictive antibody values and two-tailed 
p values were calculated (P value < 0.001=****, P value > 0.001=**, P value >0.01=*) 
We investigated a possible interaction between some of the natural isolated 
compounds and IgM antibodies in MS sera. According to these results, we can conclude that 
some saponins (4, 8, 16 and 18) are able to recognize IgMs in MS patients but the results are 
not statistically relevant compared to the synthetic peptide probe CSF114(Glc). Till now, the 
number of tested molecules is not sufficient but this study demonstrates the potential role of 
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natural compounds as mimetics of native antigens as previously hypothesized [33]. Further 
studies could be performed with new molecules in order to perform a statistically relevant 
structure/activity relationship study between IgMs and natural saponins isolated from plants. 
According to previous study, the glucosidic moiety, when present in the isolated compounds 
and not masked by the aglycone part, is fundamental for IgM recognition in Multiple 
Sclerosis. 
3.2.3 Immunoenzymatic assays on Rett syndrome patient sera 
3.2.3.1 Selection of Rett syndrome  sera 
Sera from 39 RTT patients collected at diagnosis and 22 healthy blood donors were 
obtained for diagnostic purposes and stored at −20°C until use. All patients and healthy 
donors gave their informed consent. RTT patients were previously diagnosed. Samples were 
pre-selected depending on their reactivity to CSF114(Glc). Antibody responses were 
determined in SP-ELISA. 
3.2.3.2 SP-ELISA results 
 First of all, 19 RTT sera and 11 healthy blood donors were selected for our study. 
Samples were pre-selected depending on their reactivity to CSF114(Glc). Antibody responses 
were determined by ELISA and relevant results were obtained. Each compound interacted 
with IgMs but with different statistically significance. Therefore, we increased the number of 
RTT sera and healthy blood donors Besides, samples were chosen depending on their 
reactivity to CSF114(Glc). 
Below are shown only ELISA results obtained with 39 RTT sera and 22 normal blood 
donors. Experiments were carried out as described in the Experimental part. The sera were 
used in triplicate with a dilution of 1:100. Data distribution of IgM antibodies responses to 
compounds 4, 8, 13, 14, 16, 17, 18 and 19 in the sera of RTT patients and normal blood 
donors (NBDs) determined by ELISA are herein presented: 
Column scatter of data reported in Figure 79 serological results obtained in ELISA for 
all the compounds analyzed. All compounds presented lower mean values for NBDs than for 
RTT populations. These results highlighted the potential role of natural isolated compounds 
and ursolic acid 17 as mimetics of native antigens for specific RTT IgM antibody recognition. 
Two compounds (8 and 17) presented a similar performance as the glucopeptide CSF114(Glc) 
with significant differences between patients and controls (Mann-Whitney test, p value < 
0.001). 
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Figure 79: Data distribution of IgM antibody responses to compounds 4, 8, 13, 14, 16, 17, 18 and 19 in RTT 
sera and NBDs determined by ELISA. Data are reported as absorbance at 405nm of sera diluted 1:100. Statistical 
analysis was performed using Graph prism 6 software. Mann-Whitney tests were used to evaluate the predictive 
antibody values and two-tailed p values were calculated (P value < 0.001=****, P value > 0.001=**) 
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The receiver operating characteristic (ROC) analysis was employed to compare the 
discrimination power of the compounds, and the different cutoff values, sensitivity, 
specificity, and likelyhood ratios were also calculated. Selected cutoff values, sensitivities and 
the rest of the other statistical parameters are summarized in Table 12. 
 
Table 12. Values obtained from ROC analysis of glycosides 4, 8, 13, 14, 16, 18 and 19 and ursolic 
acid 17 for the area under the curve (AUC), standard error (SE), the confidence interval (CI), p value, 
established cutoff, and the corresponding sensitivity, specificity and likelihood ratio. 
Compound AUC SE 95% 
confidence 
interval 
P value Cutoff Sensitivity 
(%) 
Specificity 
(%) 
Likelyhood 
ratio 
4 
 
0.720 0.07 0.58-0.86 0.0044 >0.924 15.38 95.45 3.38 
8 
 
0.828 0.05 0.71-0.94 <0.0001 >0.649 28.21 95.45 6.20 
13 
 
0.712 0.07 0.56-0.85 0.0062 >0.766 10.26 95.45 2.25 
14 
 
0.717 0.07 0.57-0.86 0.0049 >0.684 17.95 90.91 1.97 
16 
 
0.749 0.07 0.61-0.88 0.0013 >0.709 15.38 95.45 3.38 
17 
 
0.852 0.05 0.74-0.95 <0.0001 >0.612 33.33 95.45 7.33 
18 
 
0.706 0.06 0.57-0.84 0.0077 >0.565 15.38 95.45 3.38 
19 
 
0.755 0.06 0.63-0.87 0.0005 >0.579 25.64 88.46 2.22 
 
The characteristics of the curves, their shape and their underlying area provide 
evidence that the natural isolated glycosides and ursolic acid 17 are able to recognize RTT 
patients. The obtained values for glycosides 4, 13, 14, 16, 18 and 19 are in any case lower 
than those obtained with the glucopepide CSF114(Glc) as a synthetic antigenic probe. 
However our results highlight the role of the N-glucosyl moiety in the antibody recognition. 
The diagnostic power of saponin 8 and ursolic 17 are higher than those presented by natural 
glycosides 4, 13, 14, 16, 18 and 19 and similar to the N-glucosylated peptide CFS114(Glc). 
Moreover, we investigated the correlation between natural compounds and ursolic acid 
structures and their immunological reactivities with the CSF114(Glc) structure.  
According to previous studies on CSF114(Glc) as antigenic probe for MS and RTT 
disease, our hypothesis is that the glucosyl moiety is involved in the recognition. That is why 
different natural compounds bearing different glycosyl moieties were tested. We suppose that 
the last sugar moiety in the oligosaccharidic chain is the most exposed for IgM recognition.  
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Saponins 4, 13, 14 and 18 which are monodesmosidic molecules with different 
oligosaccharidic chains linked in C-3 position as 3-O--L-rhamnopyranosyl-(12)--D-
xylopyranosyl-(12)--D-glucuronopyranosyl, 3-O-β-D-xylopyranosyl-(12)-[β-D-
glucopyranosyl-(14)]-β-D-xylopyranosyl-(14)-β-D-xylopyranosyl-(13)-α-L-
rhamnopyranosyl-(12)-α-L-arabinopyranosyloleanolic acid, 3-O-β-D-xylopyranosyl-(13)-
α-L-rhamnopyranosyl-(12)-α-L-arabinopyranosyl and 3-O--D-glucopyranosyl 
respectively, showed similar results in spite of the difference of the sugars. They are able to 
recognise IgMs but according to their p value results they are not statistically relevant and are 
not as good as the synthetic probe CSF114(Glc).   
The bidesmosidic saponin 16 showed similar results as saponins 4, 13, 14 and 18 in 
spite of its different structure. With this consideration in mind, we can interrogate ourself 
about the importance of the sugar chain in the recognition.  
Moreover, the flavonoid glycoside 19 demonstrated a higher p value than triterpene 
saponins 4, 13, 14, 16 and 18. This compound has a different aglycone than saponins and one 
oligosaccharidic chain as α-L-rhamnopyranosyl-(16)-α-L-glucopyranosyl. According to this 
result, we cannot explain the part of the molecule involved in the IgM recognition. 
Concerning saponin 8 and ursolic acid 17 the results of ELISA are interesting and at 
the same time surprising. From a structural point of view, saponin 8 has the same 
oligosaccharidic chain as saponin 4 (3-O--L-rhamnopyranosyl-(12)--D-xylopyranosyl-
(12)--D-glucuronopyranosyl) but their aglycone part is different: compound 8 has a 
secondary alcoholic function at C-23, one acetyl group at C-22, and one carboxylic group at 
C-30, while 4 has two secondary alcoholic functions at C-23 and C-30, and a rare ketone 
group at C-22. After p value comparison, saponin 8 demonstrated a better efficiency in IgM 
recognition than saponin 4. According to these results, we can hypothesize on the possible 
role of the aglycone part in the recognition or in favouring the coating of the molecule on the 
ELISA plate and therefore exposure of the sugar moiety. Therefore, the most interesting result 
is up to now with ursolic acid 17. This triterpenic acid has no sugars, only one hydroxyl group 
at C-3 position and one carboxylic group at C-28 position. These results, let us to hypothesize 
the possible role of the aglycone part in the recognition of IgM antibodies only in the case of 
RTT syndrome. 
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We investigated the possible role in antibody recognition of compounds 4, 8, 13, 14, 
16, 17, 18 and 19 as mimetic of native antigens in the case of RTT syndrome. After 
performing immunoenzymatic assays, all the compounds displayed antibody recognition. We 
can conclude that these types of molecules are good candidates as mimetic antigens. 
Moreover, even if the number of tested molecules was not statistically significant, we 
discovered for the first time the possible role of the aglycone part in IgM recognition in Rett. 
These new results add a new molecule as possible probe to detect IgM antibodies in such 
complex disease that only recently has been proposed as an immune mediated disease [13]. 
More compounds without glycosylic part and with different triterpene-type aglycones could 
be in a near future selected and tested to confirm this hypothesis. 
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GENERAL CONCLUSION 
 
Saponins are amphiphilic glycosides, with many in vitro properties in various 
pharmacological fields. From a structural point of view, natural triterpene glycosides present 
an incredible variability of their aglycone and most of the time of their glycosyl moieties. 
According to this variability and previous collaboration, saponins demonstrated a potential 
role in detection of antibodies in multiple sclerosis. In the context of immune-mediated 
disease, the use of natural triterpene glycosides as mimetics of native antigens involving an 
immune response was investigated. 
 
The aim of this PhD was to perform the extraction, purification and structural 
elucidation of saponins from plants in order to use natural isolated compounds as antigens for 
specific antibody recognition in some selected autoimmune diseases. The purpose is to find 
the best molecules, otherwise difficult to be synthesized, to detect new classes of antibodies. 
The first chapter, deals with generalities on the immune system, autoimmunity, 
multiple sclerosis and rett syndrome. Then, a bibliographic study was realized to introduce 
and explain this research project. 
In the second chapter, a bibliographic synthesis on the family and the genus of the 
studied plants was realized. Then, the personal phytochemical study including techniques, 
methods and results were presented. This work led to the isolation and purification of sixteen 
saponins. Their structures were elucidated using a detailed 600 MHz NMR analysis including 
1D and 2D NMR (
1
H, 
13
C NMR, COSY, TOCSY, NOESY, HSQC, HMBC) experiments and 
mass spectrometry. In particular we characterized 3-O--L-rhamnopyranosyl-(12)--D-
xylopyranosyl-(12)--D-glucuronopyranosyl-22,28-O-diacetylolean-12-ene-3,16,22,28-
tetrol (1), 3-O--L-rhamnopyranosyl-(12)--D-glucopyranosyl-(12)--D-
glucuronopyranosyl-22-O-acetylolean-12-ene-3,16,22,28-tetrol (2), 3-O--L-
rhamnopyranosyl-(12)--D-xylopyranosyl-(12)--D-glucuronopyranosyl-22-O-acetyl-
3,22,24-trihydroxyolean-12-en-30-oic acid (3), 3-O--L-rhamnopyranosyl-(12)--D-
xylopyranosyl-(12)--D-glucuronopyranosyl wistariasapogenol A (wistariasaponin A) (4) , 
3-O--L-rhamnopyranosyl-(12)--D-xylopyranosyl-(12)--D-glucuronopyranosyl 
soyasapogenol B (wistariasaponin C) (5), 3-O--L-rhamnopyranosyl-(12)--D-
glucopyranosyl-(12)--D-glucuronopyranosyl soyasapogenol B (azukisaponin V) (6), 3-O-
β-D-xylopyranosyl-(12)-β-D-glucuronopyranosyl-22-O-acetyl-3β,22β,24-trihydroxyolean-
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12-en-30-oic acid (7), 3-O-α-L-rhamnopyranosyl-(12)-β-D-xylopyranosyl-(12)-β-D-
glucuronopyranosyl-22-O-acetyl-3β,22 β,24-trihydroxyolean-12-en-30-oic acid (8), 3-O-α-L-
rhamnopyranosyl-(12)-β-D-xylopyranosyl-(12)-β-D-glucuronopyranosyl-22,28-O-
diacetylolean-12-ene-3 β,16 β,22 β,28-tetrol (9), 3-O-α-L-rhamnopyranosyl-(12)-β-D-
xylopyranosyl-(12)-β-D-glucuronopyranosyl-olean-12-ene-3 β,22 β,24-triol (10) 
(Astragaloside VIII), 3-O-α-L-rhamnopyranosyl-(12)-β-D-galactopyranosyl-(12)-β-D-
glucuronopyranosyl-22-O-acetyl-3β,22 β,24-trihydroxyolean-12-en-30-oic acid (11) 
(Millettiasaponin A), 3-O-β-D-xylopyranosyl-(12)-[β-D-xylopyranosyl-(14)]-β-D-
xylopyranosyl-(14)-β-D-xylopyranosyl-(13)-α-L-rhamnopyranosyl-(12)-α-L-
arabinopyranosyloleanolic acid (12), 3-O-β-D-xylopyranosyl-(12)-[β-D-glucopyranosyl-
(14)]-β-D-xylopyranosyl-(14)-β-D-xylopyranosyl-(13)-α-L-rhamnopyranosyl-(12)-α-
L-arabinopyranosyloleanolic acid (13), 3-O-β-D-xylopyranosyl-(13)-α-L-rhamnopyranosyl-
(12)-α-L-arabinopyranosyloleanolic acid (14), 3-O-ß-D-glucopyranosyl-presenegenin-28-O-
ß-D-galactopyranosyl-(13)-ß-D-xylopyranosyl-(14)--L-rhamnopyranosyl-(12)-(3,4-di-
O-acetyl)-ß-D-fucopyranosyl ester (15) and 3-O-ß-D-glucopyranosyl-presenegenin-28-O-ß-D-
galactopyranosyl-(13)-ß-D-xylopyranosyl-(14)--L-rhamnopyranosyl-(12)-[4-O-(E)-
3,4-dimethoxycinnamoyl]-ß-D-fucopyranosyl ester (16). 
In the third chapter, eight compounds 4, 8, 13, 14, 16, ursolic acid (17), tenuifolin (18) 
and rutoside (19) were selected for immunoenzymatic assays (ELISA) that were performed on 
multiple sclerosis and rett syndrome patient sera to detect antibodies. Natural isolated 
compounds, otherwise very difficult to be synthesized, were used as mimetics of native 
antigens involved in antibody response. IgM levels were measured in the case of MS and RTT 
sera and normal blood donors as controls. No relevant results were obtained in the case of MS 
but this study confirms the relevant role of the glucosyl moiety in antibody recognition in the 
case of this disease. Concerning Rett syndrome, interesting results were obtained. Each 
compound is able to recognize IgMs in different proportions. The most relevant results were 
obtained with compounds 8 and 17, which differ for the presence or not of sugar moieties. In 
Rett syndrome, we demonstrated for the first time the new potential role of the aglycone in 
IgM recognition even if the number of tested molecules was not statistically significant.  
In conclusion, isolated saponins from a structural point of view are good candidates as 
mimetics of native antigens (otherwise difficult to be synthesized) involved in antibody 
response. 
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ABBREVIATIONS 
 
Ab  Antibodies 
Ac  Acetyl 
Ag  Antigen 
AID  AutoImmune Disease 
APC  Antigen-Presenting Cells 
APG  Angiosperm Phylogeny Group 
Api  Apiose 
Ara  Arabinose 
BCR  B Cell Receptor 
CC  Column Chromatography 
CI  Confidence Interval 
CNS  Central Nervous System 
COSY  COrrelatedSpectroscopY 
DEPT  Distortionless Enhancement by Polarization Transfer 
DMC  DiMethoxyCinnamoyl 
DNA  DesoxyriboNucleic Acid 
ELISA  Enzyme-Linked Immunosorbent Assay  
ESI  Electrospray Ionization 
Fab  Fragment antigen-binding 
FBS  Fetal Bovine Serum 
Fc  Fragment crystallizable 
Fuc  Fucose 
Gal  Galactose 
GC  Gas Chromatography 
Glc  Glucose 
GlcA  Glucuronic Acid 
HMBC Heteonuclear Multiple Bond Correlation 
HPLC  High Performance Liquid Chromatography 
HR-ESI High Resolution Electropray Ionization  
HSQC  Heteonuclear Single Quantum Correlation 
HTPLC High-Performance Thin-Layer Chromatography  
IC  Inflammatory Cell 
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Ig  Immunoglobulin 
MBP  Methyl-CpG-Binding Protein 
MeCP2 Methyl-CpG-Binding Protein 2  
MHC  Major Histocompatibility Complex 
MPLC  Medium Pressure Liquid Chromatography 
MRI  Magnetic Resonance Imaging 
MS  Multiple Sclerosis 
NBD  Normal Blood Donor 
NMR  Nuclear Magnetic Resonance 
NO  Nitric Oxide 
NOESY Nuclear Overhauser Effect SpectroscopY  
OS  Oxydative Stress 
Rha  Rhamnose 
ROC  Receiver Operating Characteristic 
ROESY Rotating-frame Overhauser Effect SpectroscopY  
RTT  Rett syndrome 
SE  Standard Error 
SP-ELISA Solid-Phase ELISA  
TCR  T Cell Receptor 
TLC  Thin-Layer Chromatography 
TOCSY Total Correlation SpectroscopY  
UV  Ultra-Violet 
VLC  Vacuum Liquid Chromatography 
Xyl  Xylose 
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